| Molecular Mechanisms Underlying Antimicrobial Resistance in Mycobacteria.
doi:10.3390/ijms27156893
|
Int J Mol Sci |
2026 |
| Whole-genome sequencing reveals lineage-associated drug resistance and enables machine learning-based prediction in Mycobacterium tuberculosis clinical isolates.
doi:10.3389/fmicb.2026.1828991
|
Front Microbiol |
2026 |
| Rapid Extensively Drug-Resistant (XDR) TB Diagnosis: An In-House DNA Biochip for Drug Resistance Detection and Mutation Profiling of Mycobacterium tuberculosis.
doi:10.1155/cjid/5518992
|
Can J Infect Dis Med Microbiol |
2026 |
| Fluoroquinolone resistance and mutation profiles in Mycobacterium tuberculosis through whole genome sequencing in Fujian province, China.
doi:10.3389/fpubh.2026.1890292
|
Front Public Health |
2026 |
| Alarming levels of fluoroquinolone resistance among MDR-TB patients in Poland: molecular and phenotypic analysis.
doi:10.3389/fcimb.2026.1881444
|
Front Cell Infect Microbiol |
2026 |
| Machine learning-based analysis of drug resistance mutations in Mycobacterium tuberculosis.
doi:10.1371/journal.pone.0352863
|
PLoS One |
2026 |
| Rapid Detection of Resistance Mutations in Multidrug-Resistant Tuberculosis With GenoType MTBDRsl Assay.
doi:10.1155/pm/6993694
|
Pulm Med |
2026 |
| Assessing Corynebacterium glutamicum as a surrogate of Mycobacterium tuberculosis for DNA gyrase inhibitor design.
doi:10.64898/2026.06.24.734172
|
bioRxiv |
2026 |
| Gemifloxacin resistance in Mycobacterium tuberculosis without QRDR mutations in gyrA or gyrB: evidence for non-canonical resistance mechanisms.
doi:10.1128/spectrum.03710-25
names it
|
Microbiol Spectr |
2026 |
| Fluoroquinolones as the linchpin of tuberculosis therapy: contrasting efficacy and resistance profiles in Mycobacterium tuberculosis versus Mycobacterium abscessus.
doi:10.3389/fcimb.2026.1833650
|
Front Cell Infect Microbiol |
2026 |
| Routine Molecular Surveillance of Drug-Resistant Tuberculosis: Translating Mutation Proxies into Clinical Governance Intelligence in Rural Eastern Cape.
doi:10.3390/healthcare14101280
|
Healthcare (Basel) |
2026 |
| Assessment of Antimicrobial Resistance in M. leprae Strains From Kiribati.
doi:10.1111/tmi.70146
|
Trop Med Int Health |
2026 |
| Assessing fluoroquinolone resistance in Mycobacterium tuberculosis using nanopore sequencing: concordance with established diagnostic methods.
doi:10.1007/s15010-026-02798-8
|
Infection |
2026 |
| Exploring Novel Gene Mutations Associated with Fluoroquinolone Resistance in Mycobacterium tuberculosis: Gene Sequencing Results from 275 Clinical Isolates in Chongqing, China.
doi:10.2147/IDR.S590990
|
Infect Drug Resist |
2026 |
| Frequency, genetic mechanisms and factors associated with fluoroquinolone (pre-XDR) and aminoglycoside resistance among multidrug-resistant tuberculosis cases in Northwestern Nigeria.
doi:10.1186/s12879-026-13191-z
|
BMC Infect Dis |
2026 |
| Development of a point-of-care dual one-step recombinase-aided PCR assay for rapid identification of Mycobacterium tuberculosis gyrA mutations conferring fluoroquinolone resistance.
doi:10.3389/fmicb.2026.1772984
names it
|
Front Microbiol |
2026 |
| Stepwise evolution and clonal enrichment of gepotidacin resistance in Neisseria gonorrhoeae.
doi:10.1128/aac.01706-25
|
Antimicrob Agents Chemother |
2026 |
| Multicentre field evaluation of Xpert MTB/XDR in sub-Saharan Africa.
doi:10.1183/23120541.00427-2025
|
ERJ Open Res |
2026 |
| In Silico Design of gRNA for CRISPR System for Detection of Multidrug Resistant Tuberculosis Using Indian Mycobacterium tuberculosis Genomes: A Computational Study.
doi:10.7759/cureus.101851
|
Cureus |
2026 |
| First insight of characteristics and prediction of Mycobacterium tuberculosis drug resistance by whole genome sequencing in Fujian Province, China.
doi:10.1038/s41598-026-40398-6
|
Sci Rep |
2026 |
| iFIND INH/FQ: a LC-aNAAT assay for rapid simultaneous detection of isoniazid and fluoroquinolone resistance in Mycobacterium tuberculosis.
doi:10.1128/spectrum.03743-25
|
Microbiol Spectr |
2026 |
| In Vitro Activity of Zoliflodacin Against Neisseria gonorrhoeae Isolates from Shanghai, China (2020-2023).
doi:10.3390/antibiotics15010061
|
Antibiotics (Basel) |
2026 |
| Resistance to anti-leprosy drugs in multi-bacillary leprosy patients: The need for transformative action.
doi:10.25259/IJDVL_1842_2024
|
Indian J Dermatol Venereol Leprol |
2026 |
| Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study.
doi:10.1016/j.lanmic.2025.101217
|
Lancet Microbe |
2026 |
| Geographical trends of drug-resistant strains of Mycobacterium leprae in TLM hospitals: insights from a four-year study across eleven hospitals in eight Indian States.
doi:10.1007/s10096-025-05351-x
|
Eur J Clin Microbiol Infect Dis |
2026 |
| Machine learning approaches to predict drug resistance in tuberculosis.
doi:10.1016/j.compbiolchem.2025.108705
|
Comput Biol Chem |
2026 |
| Metagenomic insights into the urban-rural variation of antimicrobial resistance and pathogen reservoirs in untreated wastewater from central India.
doi:10.3389/fmicb.2025.1722229
|
Front Microbiol |
2025 |
| Artificial intelligence for screening drug resistance in tuberculosis.
doi:10.25259/IJMR_1546_2025
|
Indian J Med Res |
2025 |
| The microevolutionary trajectory of endemic multidrug-resistant tuberculosis strains in Portugal toward increased drug resistance levels and its clinical significance.
doi:10.3389/fmicb.2025.1716549
|
Front Microbiol |
2025 |
| Genomic Surveillance of 3R Genes Associated with Antibiotic Resistance in Mycobacterium tuberculosis Isolates from Kazakhstan.
doi:10.3390/antibiotics15010026
|
Antibiotics (Basel) |
2025 |
| Unraveling Drug Resistance in Mycobacterium leprae: Exploring Genetic Mutations to Enhance Treatment Strategies for Human Leprosy-A Narrative Review.
doi:10.1155/ijm/7204337
|
Int J Microbiol |
2025 |
| Deciphering the population dynamics and drug-resistance characteristics of extrapulmonary tuberculosis: genomic and clinical insights from a Chinese hospital.
doi:10.3389/fcimb.2025.1692783
|
Front Cell Infect Microbiol |
2025 |
| Drug resistance profile of Mycobacterium tuberculosis in China: update until 2024.
doi:10.3389/fmicb.2025.1697490
|
Front Microbiol |
2025 |
| A novel one-tube nested fluorescence melting curve analysis for rapid detection of drug-resistant Mycobacterium tuberculosis.
doi:10.1186/s12866-025-04601-4
|
BMC Microbiol |
2025 |
| Genotypic investigation of Mycobacterium leprae in patients with relapsing leprosy in Mato Grosso, Brazil.
doi:10.1007/s00430-025-00864-w
|
Med Microbiol Immunol |
2025 |
| Evaluation of multiplex allele-specific PCR for rapid detection of isoniazid and fluoroquinolone resistance in Mycobacterium tuberculosis: A cross-sectional study in high-TB-burden settings in India.
doi:10.1016/j.ijtb.2025.06.007
|
Indian J Tuberc |
2025 |
| Whole genome sequencing-based detection of extensively drug-resistant tuberculosis from Ethiopia.
doi:10.1038/s43856-025-01271-1
|
Commun Med (Lond) |
2025 |
| Fluoroquinolone and Second-Line Injectable Resistance Among Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates: A Molecular Study from a High-Burden Setting.
doi:10.3390/microorganisms13112470
|
Microorganisms |
2025 |
| Molecular Epidemiology of Mycobacterium tuberculosis in Mexico.
doi:10.3390/microorganisms13112453
|
Microorganisms |
2025 |
| Therapeutic failure of multidrug therapy for leprosy: A retrospective case series in a hyperendemic Brazilian City.
doi:10.1371/journal.pntd.0013616
|
PLoS Negl Trop Dis |
2025 |
| Indole-containing inhibitors with improved efficacy targeting the gyrase of Mycobacterium tuberculosis.
doi:10.1093/narmme/ugae027
|
NAR Mol Med |
2025 |
| In Vitro Activity of Sulfamethoxazole-Trimethoprim, Amikacin, Oxazolidinones, Fluoroquinolones and Fidaxomicin against Isolates of Nocardia.
doi:10.1021/acsomega.5c02351
|
ACS Omega |
2025 |
| Mutations in gyrA and gyrB among drug-resistant Mycobacterium tuberculosis isolates in South Korea.
doi:10.1016/j.meegid.2025.105849
names it
|
Infect Genet Evol |
2025 |
| Antimicrobial susceptibility patterns and genotypic characteristics of Mycobacterium marinum and Mycobacterium abscessus isolated from cutaneous infections: A retrospective study.
doi:10.1016/j.jgar.2025.10.001
|
J Glob Antimicrob Resist |
2025 |
| Deciphering the Role of pafBC in Mycobacteriophage Resistance and Biofilm Formation.
doi:10.1021/acsinfecdis.5c00627
|
ACS Infect Dis |
2025 |
| Population structure and antibiotic resistance profiles of Mycobacterium tuberculosis isolates from Ibadan, Nigeria (2019-2020): a pilot study to improve affordable molecular diagnostic tools.
doi:10.3389/fpubh.2025.1657825
|
Front Public Health |
2025 |
| Genomic insights into pyrazinamide and fluoroquinolone resistance in multidrug-resistant tuberculosis in Khyber Pakhtunkhwa, Pakistan.
doi:10.1016/j.ijmm.2025.151674
|
Int J Med Microbiol |
2025 |
| Diagnostics and new treatment regimens for TB: can the Xpert MTB/XDR assay fill the gap for fluoroquinolone testing?
doi:10.1128/jcm.00643-25
|
J Clin Microbiol |
2025 |
| Whole-genome sequencing and machine learning reveal key drivers of delayed sputum conversion in rifampicin-resistant tuberculosis.
doi:10.3389/fcimb.2025.1641385
|
Front Cell Infect Microbiol |
2025 |
| Surveillance and analysis of drug resistance and drug resistance levels in multidrug resistant tuberculosis on the tropical islands of China.
doi:10.1186/s12879-025-11312-8
|
BMC Infect Dis |
2025 |
| Rapid screening of mutations for second-line-drug-resistant genes in Mycobacterium tuberculosis culture isolates by in-house developed DNA bio-chip.
doi:10.1007/s10096-025-05221-6
|
Eur J Clin Microbiol Infect Dis |
2025 |
| Whole-genome sequencing for analyzing the transmission characteristics of drug-resistant Mycobacterium tuberculosis in Ganzhou, China.
doi:10.1186/s12879-025-11356-w
|
BMC Infect Dis |
2025 |
| Lineage identification and mutation profile of Mycobacterium tuberculosis: A study from National Reference Laboratory, India.
doi:10.1016/j.ijmmb.2025.100925
|
Indian J Med Microbiol |
2025 |
| Nanopore-based targeted sequencing (NTS) for drug-resistant tuberculosis: an integrated tool for personalized treatment strategies and guidance for new drug development.
doi:10.1186/s12879-025-11227-4
|
BMC Infect Dis |
2025 |
| Prevalence and molecular characterization of drug-resistant Mycobacterium tuberculosis in Heyuan City in China.
doi:10.3389/fcimb.2025.1586938
|
Front Cell Infect Microbiol |
2025 |
| Molecular Detection of Gene Mutation Related to Drug Resistance in Mycobacterium leprae.
doi:10.4103/ijmy.ijmy_35_25
|
Int J Mycobacteriol |
2025 |
| Unearthing novel mutations and genetic variation in drug sensitive and resistant isolates of Mycobacterium tuberculosis through whole genome sequencing: A study from eastern Uttar Pradesh, India.
doi:10.1016/j.ijmmb.2025.100895
|
Indian J Med Microbiol |
2025 |
| An exploratory study on the application of nanopore sequencing for detecting Mycobacterium tuberculosis drug resistance in respiratory specimens.
doi:10.1186/s12890-025-03747-1
|
BMC Pulm Med |
2025 |
| Identification and quantification of gyrA variants in fluoroquinolone-resistant Mycobacterium tuberculosis in a MeltArray reaction.
doi:10.1128/jcm.00146-25
names it
|
J Clin Microbiol |
2025 |
| The mutant selection window of moxifloxacin and bedaquiline resistant Mycobacterium tuberculosis.
doi:10.1016/j.jinf.2025.106523
|
J Infect |
2025 |
| Patterns of Mycobacterium tuberculosis genotypes and resistance mutations in patients with pulmonary multidrug-resistant tuberculosis in Sverdlovsk Oblast, Russia.
doi:10.3389/ftubr.2025.1406536
|
Front Tuberc |
2025 |
| Genotypic analysis of drug-resistant tuberculosis in Ghana: Insights into pre-XDR and XDR-TB.
doi:10.1371/journal.pone.0323527
|
PLoS One |
2025 |
| Classic and new candidate markers for drug resistance in a large cohort of leprosy patients from the Amazon state, Brazil.
doi:10.1128/aac.01550-24
|
Antimicrob Agents Chemother |
2025 |
| Whole-genome sequencing analysis to identify antimicrobial resistance regions and virulence factors in Mycobacterium tuberculosis isolates from the Amhara Region, Ethiopia.
doi:10.1038/s41598-025-01241-6
|
Sci Rep |
2025 |
| Performance of a molecular beacon-based qPCR method for detection of fluoroquinolone resistance in Mycobacterium tuberculosis: A study confirmed by sequencing.
doi:10.1016/j.diagmicrobio.2025.116865
|
Diagn Microbiol Infect Dis |
2025 |
| Multi-drug resistance and compensatory mutations in Mycobacterium tuberculosis in Vietnam.
doi:10.1111/tmi.14104
|
Trop Med Int Health |
2025 |
| Prevalence and Genetic Profiling of Second-line Drug Resistant Tuberculosis at the Tertiary Care Center of Northern India.
doi:10.1007/s00284-025-04152-x
|
Curr Microbiol |
2025 |
| Whole genomic analysis uncovers high genetic diversity of rifampicin-resistant Mycobacterium tuberculosis strains in Botswana.
doi:10.3389/fmicb.2025.1535160
|
Front Microbiol |
2025 |
| Genetic diversity and transmission pattern of multidrug-resistant tuberculosis based on whole-genome sequencing in Wuhan, China.
doi:10.3389/fpubh.2025.1442987
|
Front Public Health |
2025 |
| Study of fluoroquinolones resistance in rifampicin-resistant tuberculosis patients in Beijing: Characteristics, trends, and treatment outcomes.
doi:10.1002/ame2.12505
|
Animal Model Exp Med |
2025 |
| Genotypic and phenotypic diversity of Mycobacterium tuberculosis strains from eastern India.
doi:10.1016/j.meegid.2025.105713
|
Infect Genet Evol |
2025 |
| Rifampicin and isoniazid resistance not promote fluoroquinolone resistance in Mycobacterium smegmatis.
doi:10.1371/journal.pone.0315512
|
PLoS One |
2025 |
| Population genetic analysis of clinical Mycobacterium abscessus complex strains in China.
doi:10.3389/fcimb.2024.1496896
|
Front Cell Infect Microbiol |
2024 |
| An Approach to Identifying Single-Nucleotide Mutations Using Noncovalent Associates of Gold Nanoparticles with Fluorescently Labeled Oligonucleotides.
doi:10.3390/ijms252413230
|
Int J Mol Sci |
2024 |
| Identification of Anti-Tuberculosis Drugs Targeting DNA Gyrase A and Serine/Threonine Protein Kinase PknB: A Machine Learning-Assisted Drug-Repurposing Approach.
doi:10.3390/tropicalmed9120288
|
Trop Med Infect Dis |
2024 |
| Evaluation of Tridax procumbens Secondary Metabolites Anti-Tuberculosis Activity by In Vitro and In Silico Methods.
doi:10.1007/s00284-024-04033-9
|
Curr Microbiol |
2024 |
| Structural Aspects of Mycobacterium tuberculosis DNA Gyrase Targeted by Novel Bacterial Topoisomerase Inhibitors.
doi:10.1021/acsmedchemlett.4c00447
|
ACS Med Chem Lett |
2024 |
| Mycobacterium tuberculosis evolution from monoresistance to pre-extensive drug resistance during a prolonged household outbreak.
doi:10.1016/j.jctube.2024.100482
|
J Clin Tuberc Other Mycobact Dis |
2024 |
| Genetic diversities and drug resistance in Mycobacterium bovis isolates from zoonotic tuberculosis using whole genome sequencing.
doi:10.1186/s12864-024-10909-8
|
BMC Genomics |
2024 |
| Levofloxacin activity at increasing doses in a murine model of fluoroquinolone-susceptible and -resistant tuberculosis.
doi:10.1128/aac.00583-24
|
Antimicrob Agents Chemother |
2024 |
| The catalogue of Mycobacterium tuberculosis mutations associated with drug resistance to 12 drugs in China from a nationwide survey: a genomic analysis.
doi:10.1016/S2666-5247(24)00131-9
|
Lancet Microbe |
2024 |
| High frequency of silent mutations in gyrA gene of Mycobacterium tuberculosis in Indian isolates.
doi:10.1002/em.22629
names it
|
Environ Mol Mutagen |
2024 |
| Risk assessment and transmission of fluoroquinolone resistance in drug-resistant pulmonary tuberculosis: a retrospective genomic epidemiology study.
doi:10.1038/s41598-024-70535-y
|
Sci Rep |
2024 |
| Epidemiology and molecular characterization of Mycobacterium tuberculosis including a drug-resistant strain associated with mortality of Asian elephants in Nepal 2019-2022.
doi:10.1016/j.tube.2024.102550
|
Tuberculosis (Edinb) |
2024 |
| Pattern and characteristics of mutations conferring resistance to second line drugs in Mycobacterium tuberculosis isolates of pulmonary and extrapulmonary TB samples.
doi:10.1016/j.ijtb.2023.07.003
|
Indian J Tuberc |
2024 |
| Drug-Resistant Profiles and Genetic Diversity of Mycobacterium Tuberculosis Revealed by Whole-Genome Sequencing in Hinggan League of Inner Mongolia, China.
doi:10.2147/IDR.S466197
|
Infect Drug Resist |
2024 |
| New generation fluoroquinolone sitafloxacin could potentially overcome the majority levofloxacin and moxifloxacin resistance in multidrug-resistant Mycobacterium tuberculosis.
doi:10.1099/jmm.0.001825
|
J Med Microbiol |
2024 |
| New insight in molecular detection of Mycobacterium tuberculosis.
doi:10.1186/s13568-024-01730-3
|
AMB Express |
2024 |
| Evaluation of genetic correlation with fluoroquinolones resistance in rifampicin-resistant Mycobacterium tuberculosis isolates.
doi:10.1016/j.heliyon.2024.e31959
|
Heliyon |
2024 |
| Drug-Resistant Characteristics, Genetic Diversity, and Transmission Dynamics of Multidrug-Resistant Mycobacterium tuberculosis in Jiangxi, China.
doi:10.2147/IDR.S460267
|
Infect Drug Resist |
2024 |
| Emergence of Neisseria gonorrhoeae Clone with Reduced Susceptibility to Sitafloxacin in China: An In Vitro and Genomic Study.
doi:10.3390/antibiotics13050468
|
Antibiotics (Basel) |
2024 |
| Acquired bedaquiline and fluoroquinolones resistance during treatment follow-up in Oromia Region, North Shewa, Ethiopia.
doi:10.1016/j.idcr.2024.e01988
|
IDCases |
2024 |
| Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study.
doi:10.1371/journal.pone.0303460
|
PLoS One |
2024 |
| Signal Propagation in the ATPase Domain of Mycobacterium tuberculosis DNA Gyrase from Dynamical-Nonequilibrium Molecular Dynamics Simulations.
doi:10.1021/acs.biochem.4c00161
|
Biochemistry |
2024 |
| Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center.
doi:10.1371/journal.pone.0301210
|
PLoS One |
2024 |
| Identification of positively selected genes in Mycobacterium tuberculosis from southern Xinjiang Uygur autonomous region of China.
doi:10.3389/fmicb.2024.1290227
|
Front Microbiol |
2024 |
| Efflux pump effects on levofloxacin resistance in Mycobacterium abscessus.
doi:10.1128/aac.01348-23
|
Antimicrob Agents Chemother |
2024 |
| Patterns and profiles of drug resistance-conferring mutations in Mycobacterium tuberculosis genotypes isolated from tuberculosis-suspected attendees of spiritual holy water sites in Northwest Ethiopia.
doi:10.3389/fpubh.2024.1356826
|
Front Public Health |
2024 |
| Whole Genome Sequence-Based Analyses of Drug Resistance Characteristics, Genetic Diversity, and Transmission Dynamics of Drug-Resistant Mycobacterium tuberculosis in Urumqi City.
doi:10.2147/IDR.S454913
|
Infect Drug Resist |
2024 |
| Recent dynamics in Neisseria gonorrhoeae genomic epidemiology in Brazil: antimicrobial resistance and genomic lineages in 2017-20 compared to 2015-16.
doi:10.1093/jac/dkae075
|
J Antimicrob Chemother |
2024 |
| [Determination Of Related Genetic Variations Resistance To Moxifloxacin From Mycobacterium Tuberculosis Strain In Hanoi From 2020 - 2022].
doi:10.51403/0868-2836/2023/1461
|
Tap Chi Y Hoc Du Phong |
2024 |
| Rapid detection of multidrug resistance in tuberculosis using nanopore-based targeted next-generation sequencing: a multicenter, double-blind study.
doi:10.3389/fmicb.2024.1349715
|
Front Microbiol |
2024 |
| Mutational Dynamics Related to Antibiotic Resistance in M. tuberculosis Isolates from Serial Samples of Patients with Tuberculosis and Type 2 Diabetes Mellitus.
doi:10.3390/microorganisms12020324
|
Microorganisms |
2024 |
| Phenotypic and Genotypic Drug Resistance of Mycobacterium tuberculosis Strains Isolated from HIV-Infected Patients from a Third-Level Public Hospital in Mexico.
doi:10.3390/pathogens13020098
|
Pathogens |
2024 |
| Whole genome sequencing for the prediction of resistant tuberculosis strains from northern India.
doi:10.1016/j.ijmmb.2024.100537
|
Indian J Med Microbiol |
2024 |
| Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand.
doi:10.1128/spectrum.03462-23
|
Microbiol Spectr |
2024 |
| Novel mutations found in Mycobacterium leprae DNA repair gene nth from central India.
doi:10.1016/j.jiac.2023.12.011
|
J Infect Chemother |
2024 |
| Genetic stability of Mycobacterium abscessus during antibiotic treatment.
doi:10.1016/j.jgar.2023.12.004
|
J Glob Antimicrob Resist |
2024 |
| High frequency of isoniazid and fluroquinolone resistance among patients with rifampicin sensitive tuberculosis.
doi:10.1016/j.diagmicrobio.2023.116159
|
Diagn Microbiol Infect Dis |
2024 |
| The emerging threat of fluroquinolone-, bedaquiline-, and linezolid-resistant Mycobacterium tuberculosis in China: Observations on surveillance data.
doi:10.1016/j.jiph.2023.11.018
|
J Infect Public Health |
2024 |
| Water network chemistry to exploit the nature of catalytic water molecules in Mtb DNA gyrase: a computational study to understand the binding mechanism of fluoroquinolones.
doi:10.1080/07391102.2023.2199869
|
J Biomol Struct Dyn |
2024 |
| Impact of Whole-Genome Sequencing of Mycobacterium tuberculosis on Treatment Outcomes for MDR-TB/XDR-TB: A Systematic Review.
doi:10.3390/pharmaceutics15122782
|
Pharmaceutics |
2023 |
| A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools.
doi:10.1371/journal.pone.0294670
|
PLoS One |
2023 |
| Direct Detection of Fluoroquinolone Resistance in Sputum Samples from Tuberculosis Patients by High Resolution Melt Curve Analysis.
doi:10.1007/s00284-023-03519-2
|
Curr Microbiol |
2023 |
| Comparison of the in vitro antibacterial activity of ofloxacin, levofloxacin, moxifloxacin, sitafloxacin, finafloxacin, and delafloxacin against Mycobacterium tuberculosis strains isolated in China.
doi:10.1016/j.heliyon.2023.e21216
|
Heliyon |
2023 |
| Systematic investigation of the emerging pathogen of Tsukamurella species in a Chinese tertiary teaching hospital.
doi:10.1128/spectrum.01644-23
|
Microbiol Spectr |
2023 |
| Amino acid 17 in QRDR of Gyrase A plays a key role in fluoroquinolones susceptibility in mycobacteria.
doi:10.1128/spectrum.02809-23
|
Microbiol Spectr |
2023 |
| Antimicrobial Resistance and Molecular Typing of Neisseria gonorrhoeae Isolates From the Eastern Cape Province in South Africa.
doi:10.1097/OLQ.0000000000001877
|
Sex Transm Dis |
2023 |
| Re-evaluation of critical concentrations of antituberculosis fluoroquinolones in the Mycobacteria Growth Indicator Tube 960 system.
doi:10.4103/ijmy.ijmy_144_23
|
Int J Mycobacteriol |
2023 |
| Genotype MTBDRsl version 2 and phenotypic drug resistance detection of Mycobacterium tuberculosis for fluoroquinolones and aminoglycosides.
doi:10.4103/ijmy.ijmy_120_23
|
Int J Mycobacteriol |
2023 |
| Fluoroquinolone resistance mutations among Mycobacterium tuberculosis and their interconnection with treatment outcome.
doi:10.4103/ijmy.ijmy_116_23
|
Int J Mycobacteriol |
2023 |
| Genetic surveillance and outcomes of pyrazinamide and fluoroquinolones-resistant tuberculosis in Taiwan.
doi:10.1016/j.jmii.2023.08.013
|
J Microbiol Immunol Infect |
2023 |
| Molecular Analysis of Anti-Tuberculosis Drug Resistance of Mycobacterium tuberculosis Isolated in the Republic of Korea.
doi:10.3390/antibiotics12081324
|
Antibiotics (Basel) |
2023 |
| Whole genome sequencing of drug resistance Mycobacterium tuberculosis from extra-pulmonary sites.
doi:10.26508/lsa.202302076
|
Life Sci Alliance |
2023 |
| Correlating clinical breakpoint concentration of moxifloxacin with gyrA mutations using the GenoType MTBDRsl assay Version 2.0.
doi:10.1016/j.ijtb.2022.11.004
names it
|
Indian J Tuberc |
2023 |
| Whole Genomic Analysis Revealed High Genetic Diversity and Drug-Resistant Characteristics of Mycobacterium tuberculosis in Guangxi, China.
doi:10.2147/IDR.S410828
|
Infect Drug Resist |
2023 |
| Deciphering the emerging role of phytocompounds: Implications in the management of drug-resistant tuberculosis and ATDs-induced hepatic damage.
doi:10.1016/j.jiph.2023.07.016
|
J Infect Public Health |
2023 |
| Characterization of Genetic Mutations in Multi-Drug-Resistant Isolates of Mycobacterium tuberculosis Bacilli Conferring Resistance to a Second-Line Anti-tuberculosis Drug.
doi:10.7759/cureus.40442
|
Cureus |
2023 |
| Rapid detection of fluoroquinolone resistance in Mycobacterium tuberculosis using a novel multienzyme isothermal rapid assay.
doi:10.1038/s41429-023-00639-6
|
J Antibiot (Tokyo) |
2023 |
| Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India.
doi:10.3390/medicina59061005
|
Medicina (Kaunas) |
2023 |
| Whole-genome sequencing reveals genotypic resistance in phenotypically susceptible Mycobacterium tuberculosis clinical isolates.
doi:10.4103/ijmy.ijmy_101_23
|
Int J Mycobacteriol |
2023 |
| Hi-plex deep amplicon sequencing for identification, high-resolution genotyping and multidrug resistance prediction of Mycobacterium leprae directly from patient biopsies by using Deeplex Myc-Lep.
doi:10.1016/j.ebiom.2023.104649
|
EBioMedicine |
2023 |
| Comparison of the Diagnostic Performance of MeltPro and Next-Generation Sequencing in Determining Fluoroquinolone Resistance in Multidrug-Resistant Tuberculosis Isolates.
doi:10.1016/j.jmoldx.2023.02.003
|
J Mol Diagn |
2023 |
| Profile and Frequency of Mutations Conferring Drug-Resistant Tuberculosis in the Central, Southeastern and Eastern Ethiopia.
doi:10.2147/IDR.S408567
|
Infect Drug Resist |
2023 |
| Mycobacterium tuberculosis Intra-Host Evolution Among Drug-Resistant Tuberculosis Patients Failing Treatment.
doi:10.2147/IDR.S408976
|
Infect Drug Resist |
2023 |
| Distinct subunit architecture and assembly pattern of DNA gyrase from mycobacteria.
doi:10.1111/mmi.15068
|
Mol Microbiol |
2023 |
| Emergence and evolution of drug-resistant Mycobacterium tuberculosis in eastern China: A six-year prospective study.
doi:10.1016/j.ygeno.2023.110640
|
Genomics |
2023 |
| Strain diversity in Mycobacterium avium subsp. paratuberculosis-positive bovine fecal samples collected in Switzerland.
doi:10.3389/fvets.2023.1154516
|
Front Vet Sci |
2023 |
| Evaluation of genetic mutations associated with phenotypic resistance to fluoroquinolones, bedaquiline, and linezolid in clinical Mycobacterium tuberculosis: A systematic review and meta-analysis.
doi:10.1016/j.jgar.2023.05.001
|
J Glob Antimicrob Resist |
2023 |
| Comprehensive Drug Resistance Characterization of Pulmonary Tuberculosis in Algeria: Insights on Mycobacterium tuberculosis Strains by Whole-Genome Sequencing.
doi:10.1089/mdr.2022.0321
|
Microb Drug Resist |
2023 |
| Evaluation of Microsphere-based xMAP Test for gyrA Mutation Identification in Mycobacterium Tuberculosis.
doi:10.3967/bes2023.046
names it
|
Biomed Environ Sci |
2023 |
| Characterization of DNA Gyrase Activity and Elucidation of the Impact of Amino Acid Substitution in GyrA on Fluoroquinolone Resistance in Mycobacterium avium.
doi:10.1128/spectrum.05088-22
names it
|
Microbiol Spectr |
2023 |
| Simplified cloning and isolation of peptides from "sandwiched" SUMO-peptide-intein fusion proteins.
doi:10.1186/s12896-023-00779-5
|
BMC Biotechnol |
2023 |
| Advantages of analysing both pairwise SNV-distance and differing SNVs between Mycobacterium tuberculosis isolates for recurrent tuberculosis cause determination.
doi:10.1099/mgen.0.000956
|
Microb Genom |
2023 |
| Endogenous relapse and exogenous reinfection in recurrent pulmonary tuberculosis: A retrospective study revealed by whole genome sequencing.
doi:10.3389/fmicb.2023.1115295
|
Front Microbiol |
2023 |
| Whole-genome sequencing-based analyses of drug-resistant Mycobacterium tuberculosis from Taiwan.
doi:10.1038/s41598-023-29652-3
|
Sci Rep |
2023 |
| Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort.
doi:10.1128/jcm.01478-22
|
J Clin Microbiol |
2023 |
| MTBDRplus and MTBDRsl for simultaneous diagnosis of gastrointestinal tuberculosis and detection of first-line and second-line drug resistance.
doi:10.1111/jgh.16124
|
J Gastroenterol Hepatol |
2023 |
| Molecular Characterization of Resistance to Second-Line Anti-Mycobacterial Drugs among Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis.
doi:10.7754/Clin.Lab.2022.220211
|
Clin Lab |
2023 |
| Strain diversity and gene mutations associated with presumptive multidrug-resistant Mycobacterium tuberculosis complex isolates in Northwest Ethiopia.
doi:10.1016/j.jgar.2022.11.012
|
J Glob Antimicrob Resist |
2023 |
| GenoType MTBDRsl for detection of second-line drugs and ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates at a high-throughput laboratory.
doi:10.1016/j.diagmicrobio.2022.115856
|
Diagn Microbiol Infect Dis |
2023 |
| Resistance patterns among drug-resistant tuberculosis patients and trends-over-time analysis of national surveillance data in Gabon, Central Africa.
doi:10.1007/s15010-022-01941-5
|
Infection |
2023 |
| Drug resistance profiles and related gene mutations in slow-growing non-tuberculous mycobacteria isolated in regional tuberculosis reference laboratories of Iran: a three year cross-sectional study.
doi:10.1080/20477724.2022.2049029
|
Pathog Glob Health |
2023 |
| The past, present and future of tuberculosis treatment.
doi:10.3724/zdxbyxb-2022-0454
|
Zhejiang Da Xue Xue Bao Yi Xue Ban |
2022 |
| Analysis of drug resistance among difficult-to-treat tuberculosis patients in Ghana identifies several pre-XDR TB cases.
doi:10.3389/fmicb.2022.1069292
|
Front Microbiol |
2022 |
| Comparative genome analysis reveals high-level drug resistance markers in a clinical isolate of Mycobacterium fortuitum subsp. fortuitum MF GZ001.
doi:10.3389/fcimb.2022.1056007
|
Front Cell Infect Microbiol |
2022 |
| Genomic analysis of Mycobacterium tuberculosis variant bovis strains isolated from bovine in the state of Mato Grosso, Brazil.
doi:10.3389/fvets.2022.1006090
|
Front Vet Sci |
2022 |
| High diversity of clinical Mycobacterium intracellulare in China revealed by whole genome sequencing.
doi:10.3389/fpubh.2022.989587
|
Front Public Health |
2022 |
| Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis.
doi:10.3390/ijms232012443
|
Int J Mol Sci |
2022 |
| Pre-extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in Ethiopia: a laboratory-based surveillance study.
doi:10.1016/j.ijregi.2022.08.012
|
IJID Reg |
2022 |
| Detection of Mutations in pncA in Mycobacterium tuberculosis Clinical Isolates from Nepal in Association with Pyrazinamide Resistance.
doi:10.3390/cimb44090283
|
Curr Issues Mol Biol |
2022 |
| Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran.
doi:10.1371/journal.pone.0267320
|
PLoS One |
2022 |
| Molecular Surveillance of Antimicrobial Resistance of Mycobacterium leprae from Leprosy Patients in Zhejiang Province, China.
doi:10.2147/IDR.S368682
|
Infect Drug Resist |
2022 |
| Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study.
doi:10.1016/S2666-5247(22)00117-3
|
Lancet Microbe |
2022 |
| Diagnostic utility of GenoType MTBDRsl assay for the detection of moxifloxacin-resistant mycobacterium tuberculosis, as compared to phenotypic method and whole-genome sequencing.
doi:10.4103/ijmy.ijmy_70_22
|
Int J Mycobacteriol |
2022 |
| Sensitivity of different DNA extraction methods and PCR to detect resistance in patients with leprosy stratified by the bacilloscopic index.
doi:10.1016/j.bjid.2022.102381
|
Braz J Infect Dis |
2022 |
| Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: a threat to effective secondary line treatment for rifampicin-resistant leprosy cases.
doi:10.1016/j.jgar.2022.06.008
|
J Glob Antimicrob Resist |
2022 |
| [Exploratory study on detection of drug resistance of Mycobacterium tuberculosis in sputum specimens by next-generation sequencing].
doi:10.3760/cma.j.cn112147-20211104-00775
|
Zhonghua Jie He He Hu Xi Za Zhi |
2022 |
| Utility of line probe assay in detecting drug resistance and the associated mutations in patients with extrapulmonary tuberculosis in Addis Ababa, Ethiopia.
doi:10.1177/20503121221098241
|
SAGE Open Med |
2022 |
| Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of Mycobacterium tuberculosis in re-treated patients.
doi:10.1016/j.tube.2022.102209
|
Tuberculosis (Edinb) |
2022 |
| First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda.
doi:10.1186/s13756-022-01101-2
|
Antimicrob Resist Infect Control |
2022 |
| Performance of the GenoType MTBDRsl in a programmatic setting, South Africa.
doi:10.5588/ijtld.21.0590
|
Int J Tuberc Lung Dis |
2022 |
| Spiropyrimidinetrione DNA Gyrase Inhibitors with Potent and Selective Antituberculosis Activity.
doi:10.1021/acs.jmedchem.2c00266
|
J Med Chem |
2022 |
| Intra-host genetic population diversity: Role in emergence and persistence of drug resistance among Mycobacterium tuberculosis complex minor variants.
doi:10.1016/j.meegid.2022.105288
|
Infect Genet Evol |
2022 |
| Utility of Multi-target Nested PCR and ELISPOT Assays for the Detection of Paucibacillary Leprosy: A Possible Conclusion of Clinical Laboratory Misdiagnosis.
doi:10.3389/fcimb.2022.814413
|
Front Cell Infect Microbiol |
2022 |
| Characterization of Fluoroquinolone-Resistant and Multidrug-Resistant Mycobacterium tuberculosis Isolates Using Whole-Genome Sequencing in Tianjin, China.
doi:10.2147/IDR.S361635
|
Infect Drug Resist |
2022 |
| Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.
doi:10.1128/aac.02170-21
|
Antimicrob Agents Chemother |
2022 |
| Molecular Epidemiology and Polymorphism Analysis in Drug-Resistant Genes in M. tuberculosis Clinical Isolates from Western and Northern India.
doi:10.2147/IDR.S345855
|
Infect Drug Resist |
2022 |
| Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year's review.
doi:10.1186/s12879-022-07339-w
|
BMC Infect Dis |
2022 |
| Application of Amplicon-Based Targeted NGS Technology for Diagnosis of Drug-Resistant Tuberculosis Using FFPE Specimens.
doi:10.1128/spectrum.01358-21
|
Microbiol Spectr |
2022 |
| Whole-genome sequencing of Mycobacterium tuberculosis for prediction of drug resistance.
doi:10.1017/S095026882100279X
|
Epidemiol Infect |
2022 |
| Molecular Characterization of Mycobacterium ulcerans DNA Gyrase and Identification of Mutations Reducing Susceptibility to Quinolones In Vitro.
doi:10.1128/AAC.01902-21
|
Antimicrob Agents Chemother |
2022 |
| Clinical and Microbiological Characteristics of Mycobacterium kansasii Pulmonary Infections in China.
doi:10.1128/spectrum.01475-21
|
Microbiol Spectr |
2022 |
| Molecular Characteristic of Both Levofloxacin and Moxifloxacin Resistance in Mycobacterium tuberculosis from Individuals Diagnosed with Preextensive Drug-Resistant Tuberculosis.
doi:10.1089/mdr.2021.0212
|
Microb Drug Resist |
2022 |
| A CRISPR-based nucleic acid detection platform (CRISPR-CPA): Application for detection of Nocardia farcinica.
doi:10.1111/jam.15424
|
J Appl Microbiol |
2022 |
| Mutations associated with Helicobacter pylori antimicrobial resistance in the Ecuadorian population.
doi:10.1111/jam.15396
|
J Appl Microbiol |
2022 |
| Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China.
doi:10.1016/j.cmi.2021.09.014
|
Clin Microbiol Infect |
2022 |
| Equal rates of drug resistance in leprosy cases with relapse and recurrent/chronic Type 2 reaction: time to revise the guidelines for drug-resistance testing in leprosy?
doi:10.1111/ced.14884
|
Clin Exp Dermatol |
2022 |
| DNA Methyltransferase HsdM Induce Drug Resistance on Mycobacterium tuberculosis via Multiple Effects.
doi:10.3390/antibiotics10121544
|
Antibiotics (Basel) |
2021 |
| Whole Genome Sequencing of Drug Resistant and Drug Susceptible Mycobacterium tuberculosis Isolates From Tigray Region, Ethiopia.
doi:10.3389/fmicb.2021.743198
|
Front Microbiol |
2021 |
| Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh.
doi:10.1371/journal.pone.0261329
|
PLoS One |
2021 |
| Putative extensive and pre-extensive drug resistant-tuberculosis associated with unusual genotypes on the Thailand-Myanmar border.
doi:10.1590/S1678-9946202163085
|
Rev Inst Med Trop Sao Paulo |
2021 |
| Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
doi:10.1128/Spectrum.00409-21
|
Microbiol Spectr |
2021 |
| Correlation of gyr Mutations with the Minimum Inhibitory Concentrations of Fluoroquinolones among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Bangladesh.
doi:10.3390/pathogens10111422
|
Pathogens |
2021 |
| Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China.
doi:10.3390/antibiotics10111367
|
Antibiotics (Basel) |
2021 |
| Characterizing the gene mutations associated with resistance to gatifloxacin in Mycobacterium tuberculosis through whole-genome sequencing.
doi:10.1016/j.ijid.2021.09.028
|
Int J Infect Dis |
2021 |
| Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition.
doi:10.1186/s13756-021-00995-8
|
Antimicrob Resist Infect Control |
2021 |
| Simultaneous Determination of Mycobacterium leprae Drug Resistance and Single-Nucleotide Polymorphism Genotype by Use of Nested Multiplex PCR with Amplicon Sequencing.
doi:10.1128/JCM.00814-21
|
J Clin Microbiol |
2021 |
| Screening of Compounds for Anti-tuberculosis Activity, and in vitro and in vivo Evaluation of Potential Candidates.
doi:10.3389/fmicb.2021.658637
|
Front Microbiol |
2021 |
| A systematic review of Mycobacterium leprae DNA gyrase mutations and their impact on fluoroquinolone resistance.
doi:10.1016/j.cmi.2021.07.007
|
Clin Microbiol Infect |
2021 |
| Genotypic diversity of multi- and pre-extremely drug-resistant Mycobacterium tuberculosis isolates from Morocco.
doi:10.1371/journal.pone.0253826
|
PLoS One |
2021 |
| Mycobacterium setense isolated from a cat with atypical mycobacterial panniculitis.
doi:10.1055/a-1528-1763
|
Tierarztl Prax Ausg K Kleintiere Heimtiere |
2021 |
| Whole-genome analysis of drug-resistant Mycobacterium tuberculosis reveals novel mutations associated with fluoroquinolone resistance.
doi:10.1016/j.ijantimicag.2021.106385
|
Int J Antimicrob Agents |
2021 |
| Clinical implications of high-risk mutations in drug resistant tuberculosis (DR-TB): An observational cohort study.
doi:10.1016/j.ijmmb.2021.05.020
|
Indian J Med Microbiol |
2021 |
| Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan.
doi:10.1038/s41598-021-91757-4
|
Sci Rep |
2021 |
| Highly transmitted M. tuberculosis strains are more likely to evolve MDR/XDR and cause outbreaks, but what makes them highly transmitted?
doi:10.1016/j.tube.2021.102092
|
Tuberculosis (Edinb) |
2021 |
| Distribution of fluoroquinolone resistance determinants in Carbapenem-resistant Klebsiella pneumoniae clinical isolates associated with bloodstream infections in China.
doi:10.1186/s12866-021-02238-7
|
BMC Microbiol |
2021 |
| Computational modeling and bioinformatic analyses of functional mutations in drug target genes in Mycobacterium tuberculosis.
doi:10.1016/j.csbj.2021.04.034
|
Comput Struct Biotechnol J |
2021 |
| Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus.
doi:10.1128/AAC.00676-21
|
Antimicrob Agents Chemother |
2021 |
| Comparative in vitro susceptibility of a novel fluoroquinolone antibiotic candidate WFQ-228, levofloxacin, and moxifloxacin against Mycobacterium tuberculosis.
doi:10.1016/j.ijid.2021.04.036
|
Int J Infect Dis |
2021 |
| Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait.
doi:10.1038/s41598-021-87516-0
|
Sci Rep |
2021 |
| Molecular characterization of multidrug-resistant tuberculosis against levofloxacin, moxifloxacin, bedaquiline, linezolid, clofazimine, and delamanid in southwest of China.
doi:10.1186/s12879-021-06024-8
|
BMC Infect Dis |
2021 |
| Molecular Characteristics and Drug Resistance of Mycobacterium tuberculosis Isolate Circulating in Shaanxi Province, Northwestern China.
doi:10.1089/mdr.2020.0496
|
Microb Drug Resist |
2021 |
| Exploratory development of PCR-fluorescent probes in rapid detection of mutations associated with extensively drug-resistant tuberculosis.
doi:10.1007/s10096-021-04236-z
|
Eur J Clin Microbiol Infect Dis |
2021 |
| Molecular characterization of mutations associated with resistance to second line drugs in Mycobacterium tuberculosis patients from Casablanca, Morocco.
doi:10.1590/S1678-9946202163019
|
Rev Inst Med Trop Sao Paulo |
2021 |
| Resistance to Second-Line Anti-TB Drugs in Cambodia: A Phenotypic and Genetic Study.
doi:10.2147/IDR.S289907
|
Infect Drug Resist |
2021 |
| Molecular epidemiology of Mycobacterium tuberculosis in adult Filipino TB-HIV co-infected patients.
doi:10.5588/ijtld.20.0878
|
Int J Tuberc Lung Dis |
2021 |
| Clinical outcomes and molecular characterization of drug-resistant tuberculosis in pre- and extensively drug-resistant disease based on line probe assays.
doi:10.1016/j.bjid.2021.101544
|
Braz J Infect Dis |
2021 |
| Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: A subsequent study of a national survey.
doi:10.1016/j.jinf.2021.02.004
|
J Infect |
2021 |
| Moxifloxacin Activates the SOS Response in Mycobacterium tuberculosis in a Dose- and Time-Dependent Manner.
doi:10.3390/microorganisms9020255
|
Microorganisms |
2021 |
| Drug resistance gene mutations and treatment outcomes in MDR-TB: A prospective study in Eastern China.
doi:10.1371/journal.pntd.0009068
|
PLoS Negl Trop Dis |
2021 |
| Drug-resistant Mycobacterium tuberculosis and its genotypes isolated from an outbreak in western Thailand.
doi:10.1093/trstmh/traa148
|
Trans R Soc Trop Med Hyg |
2021 |
| Genotyping and Molecular Characterization of Fluoroquinolone's Resistance Among Multidrug-Resistant Mycobacterium tuberculosis in Southwest of China.
doi:10.1089/mdr.2019.0339
|
Microb Drug Resist |
2021 |
| Frequency and patterns of first- and second-line drug resistance-conferring mutations in Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients in a cross-sectional study in Tigray Region, Ethiopia.
doi:10.1016/j.jgar.2020.11.017
|
J Glob Antimicrob Resist |
2021 |
| An explainable machine learning platform for pyrazinamide resistance prediction and genetic feature identification of Mycobacterium tuberculosis.
doi:10.1093/jamia/ocaa233
|
J Am Med Inform Assoc |
2021 |
| Emergence of Specific gyrA Mutations Associated High-Level Fluoroquinolone-Resistant Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Cases in North India.
doi:10.1089/mdr.2020.0240
names it
|
Microb Drug Resist |
2021 |
| Resistance-Conferring Mutations on Whole-Genome Sequencing of Fluoroquinolone-resistant and -Susceptible Mycobacterium tuberculosis Isolates: A Proposed Threshold for Identifying Resistance.
doi:10.1093/cid/ciaa496
|
Clin Infect Dis |
2021 |
| Simultaneous Detection of Drug-resistant Mutations in Mycobacterium tuberculosis and Determining their Role through In Silico Docking.
doi:10.2174/1871526520666200318111140
|
Infect Disord Drug Targets |
2021 |
| Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB.
doi:10.1371/journal.pone.0244829
|
PLoS One |
2020 |
| Design, Synthesis and Pharmacological Evaluation of Some C(3) Heterocyclic-Substituted Ciprofloxacin Derivatives as Chimeric Antitubercular Agents.
doi:10.1248/cpb.c20-00525
|
Chem Pharm Bull (Tokyo) |
2020 |
| Pulmonary infection due to fluoroquinolone-resistant Mycolicibacterium fortuitum: a case report.
doi:10.1186/s12879-020-05596-1
|
BMC Infect Dis |
2020 |
| Molecular Evaluation of Fluoroquinolone Resistance in Serial Mycobacterium tuberculosis Isolates from Individuals Diagnosed with Multidrug-Resistant Tuberculosis.
doi:10.1128/AAC.01663-20
|
Antimicrob Agents Chemother |
2020 |
| Laboratory Evaluation of a Lateral-Flow Cell for Molecular Detection of First-Line and Second-Line Antituberculosis Drug Resistance.
doi:10.1128/JCM.01417-20
|
J Clin Microbiol |
2020 |
| Cascade of deoxyribozymes for the colorimetric analysis of drug resistance in Mycobacterium tuberculosis.
doi:10.1016/j.bios.2020.112385
|
Biosens Bioelectron |
2020 |
| Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran.
doi:10.1016/j.meegid.2020.104468
|
Infect Genet Evol |
2020 |
| Specific gyrA Gene Mutations Correlate with High Prevalence of Discordant Levofloxacin Resistance in Mycobacterium tuberculosis Isolates from Beijing, China.
doi:10.1016/j.jmoldx.2020.06.010
names it
|
J Mol Diagn |
2020 |
| Survey of drug resistance associated gene mutations in Mycobacterium tuberculosis, ESKAPE and other bacterial species.
doi:10.1038/s41598-020-65766-8
|
Sci Rep |
2020 |
| Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran.
doi:10.1186/s12879-020-05112-5
|
BMC Infect Dis |
2020 |
| Genomic signatures of drug resistance in highly resistant Mycobacterium tuberculosis strains of the early ancient sublineage of Beijing genotype in Russia.
doi:10.1016/j.ijantimicag.2020.106036
|
Int J Antimicrob Agents |
2020 |
| Genotype analysis of ofloxacin-resistant multidrug-resistant Mycobacterium tuberculosis isolates in a multicentered study from India.
doi:10.4103/ijmr.IJMR_493_18
|
Indian J Med Res |
2020 |
| [Analysis on drug resistance-associated mutations of multi-drug resistant Mycobacterium tuberculosis based on whole-genome sequencing in China].
doi:10.3760/cma.j.cn112338-20191111-00800
|
Zhonghua Liu Xing Bing Xue Za Zhi |
2020 |
| Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil.
doi:10.1590/0074-02760200055
|
Mem Inst Oswaldo Cruz |
2020 |
| Fluoroquinolone resistance and mutational profile of gyrA in pulmonary MDR tuberculosis patients.
doi:10.1186/s12890-020-1172-4
names it
|
BMC Pulm Med |
2020 |
| Detection of drug resistant Mycobacterium tuberculosis by high-throughput sequencing of DNA isolated from acid fast bacilli smears.
doi:10.1371/journal.pone.0232343
|
PLoS One |
2020 |
| Bacterial population kinetics in heteroresistant Mycobacterium tuberculosis harbouring rare resistance-conferring mutations in gyrA and rpoB imply an epistatic interaction of mutations in a pre-XDR-TB patient.
doi:10.1093/jac/dkaa109
names it
|
J Antimicrob Chemother |
2020 |
| Artificial Intelligence and Machine learning based prediction of resistant and susceptible mutations in Mycobacterium tuberculosis.
doi:10.1038/s41598-020-62368-2
|
Sci Rep |
2020 |
| Second-line Drug Resistance Characterization in Mycobacterium tuberculosis by Genotype MTBDRsl Assay.
doi:10.2991/jegh.k.191215.003
|
J Epidemiol Glob Health |
2020 |
| Association Between the Phenotype and Genotype of Isoniazid Resistance Among Mycobacterium tuberculosis Isolates in Thailand.
doi:10.2147/IDR.S242261
|
Infect Drug Resist |
2020 |
| Molecular characterisation of mutations associated with resistance to first- and second-line drugs among Indonesian patients with tuberculosis.
doi:10.1016/j.jtumed.2019.12.003
|
J Taibah Univ Med Sci |
2020 |
| Metabolic Changes of Mycobacterium tuberculosis during the Anti-Tuberculosis Therapy.
doi:10.3390/pathogens9020131
|
Pathogens |
2020 |
| Molecular characterization of pre-extensive drug resistant Mycobacterium tuberculosis in Northeast Brazil.
doi:10.1590/S1678-9946202062004
|
Rev Inst Med Trop Sao Paulo |
2020 |
| Burden of baseline resistance of Mycobacterium tuberculosis to fluoroquinolones and second-line injectables in central India.
doi:10.1093/trstmh/trz121
|
Trans R Soc Trop Med Hyg |
2020 |
| The molecular patterns of resistance to anti-tuberculosis drugs: an analysis from Istanbul, Turkey.
doi:10.1080/1120009X.2020.1716477
|
J Chemother |
2020 |
| Increased prevalence of levofloxacin-resistant Mycobacterium tuberculosis in China is associated with specific mutations within the gyrA gene.
doi:10.1016/j.ijid.2020.01.021
names it
|
Int J Infect Dis |
2020 |
| Epidemiological cut-offs for Sensititre susceptibility testing of Mycobacterium tuberculosis: interpretive criteria cross validated with whole genome sequencing.
doi:10.1038/s41598-020-57992-x
|
Sci Rep |
2020 |
| Functional interactions between gyrase subunits are optimized in a species-specific manner.
doi:10.1074/jbc.RA119.010245
|
J Biol Chem |
2020 |
| Evidence for Mycobacterium leprae Drug Resistance in a Large Cohort of Leprous Neuropathy Patients from India.
doi:10.4269/ajtmh.19-0390
|
Am J Trop Med Hyg |
2020 |
| WQ-3810: A new fluoroquinolone with a high potential against fluoroquinolone-resistant Mycobacterium tuberculosis.
doi:10.1016/j.tube.2019.101891
|
Tuberculosis (Edinb) |
2020 |
| Bacillus Calmette-Guérin strains with defined resistance mutations: a new tool for tuberculosis laboratory quality control.
doi:10.1016/j.cmi.2019.10.033
|
Clin Microbiol Infect |
2020 |
| The Genetic Background Modulates the Evolution of Fluoroquinolone-Resistance in Mycobacterium tuberculosis.
doi:10.1093/molbev/msz214
|
Mol Biol Evol |
2020 |
| Emergence and Transmission of Drug-/Multidrug-resistant Mycobacterium leprae in a Former Leprosy Colony in the Brazilian Amazon.
doi:10.1093/cid/ciz570
|
Clin Infect Dis |
2020 |
| Elucidation of drug resistance mutations in Mycobacterium tuberculosis isolates from North India by whole-genome sequencing.
doi:10.1016/j.jgar.2019.05.019
|
J Glob Antimicrob Resist |
2020 |
| Evaluation of MTBDRsl for detecting resistance in Mycobacterium tuberculosis to second-line drugs.
doi:10.5588/ijtld.18.0562
|
Int J Tuberc Lung Dis |
2019 |
| Phenotypic and genotypic characterization of levofloxacin- and moxifloxacin-resistant Mycobacterium tuberculosis clinical isolates in southern China.
doi:10.21037/jtd.2019.11.03
|
J Thorac Dis |
2019 |
| Nested PCR and the TaqMan SNP Genotyping Assay enhanced the sensitivity of drug resistance testing of Mycobacterium leprae using clinical specimens of leprosy patients.
doi:10.1371/journal.pntd.0007946
|
PLoS Negl Trop Dis |
2019 |
| Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana.
doi:10.3390/pathogens8040208
|
Pathogens |
2019 |
| Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan.
doi:10.1038/s41598-019-51562-6
|
Sci Rep |
2019 |
| Molecular surveillance of antimicrobial resistance and transmission pattern of Mycobacterium leprae in Chinese leprosy patients.
doi:10.1080/22221751.2019.1677177
|
Emerg Microbes Infect |
2019 |
| A multilocus sequence typing scheme for Mycobacterium abscessus complex (MAB-multilocus sequence typing) using whole-genome sequencing data.
doi:10.4103/ijmy.ijmy_106_19
|
Int J Mycobacteriol |
2019 |
| A Rare D94F Change in gyrA Gene of Multidrug-Resistant Mycobacterium tuberculosis Possibly Contributing to an Unfavorable Treatment Outcome.
doi:10.1128/AAC.01312-19
names it
|
Antimicrob Agents Chemother |
2019 |
| Prevalence, risk and genetic characteristics of drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.
doi:10.2147/IDR.S209971
|
Infect Drug Resist |
2019 |
| Three-reaction high-resolution melting assay for rapid differentiation of Mycobacterium tuberculosis complex members.
doi:10.1002/mbo3.919
|
Microbiologyopen |
2019 |
| Mutation and Transmission Profiles of Second-Line Drug Resistance in Clinical Isolates of Drug-Resistant Mycobacterium tuberculosis From Hebei Province, China.
doi:10.3389/fmicb.2019.01838
|
Front Microbiol |
2019 |
| [Detection and Molecular Analysis of Moxifloxacin MIC Values of Mycobacterium tuberculosis Strains Isolated from Clinical Specimens].
doi:10.5578/mb.68291
|
Mikrobiyol Bul |
2019 |
| Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations.
doi:10.1038/s41598-019-48289-9
|
Sci Rep |
2019 |
| DNA gyrase could be a crucial regulatory factor for growth and survival of Mycobacterium leprae.
doi:10.1038/s41598-019-47364-5
|
Sci Rep |
2019 |
| Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).
doi:10.1186/s12890-019-0891-x
|
BMC Pulm Med |
2019 |
| Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan.
doi:10.1016/j.jiac.2019.05.028
|
J Infect Chemother |
2019 |
| Diagnostic predictive values of the Hain genotype MTBDRsl assay in mycobacterial strains isolated from Sudan.
doi:10.11604/pamj.2019.32.124.12762
|
Pan Afr Med J |
2019 |
| First genetic characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from Algeria.
doi:10.1016/j.jgar.2019.05.010
|
J Glob Antimicrob Resist |
2019 |
| Using Mycobacterium tuberculosis Single-Nucleotide Polymorphisms To Predict Fluoroquinolone Treatment Response.
doi:10.1128/AAC.00076-19
|
Antimicrob Agents Chemother |
2019 |
| Report of a Leprosy case in Singapore: an age-old disease not to be forgotten in developed countries with low-prevalence settings.
doi:10.1099/acmi.0.000014
|
Access Microbiol |
2019 |
| Characterisation of drug resistance-associated mutations among clinical multidrug-resistant Mycobacterium tuberculosis isolates from Hebei Province, China.
doi:10.1016/j.jgar.2019.03.012
|
J Glob Antimicrob Resist |
2019 |
| Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.
doi:10.1186/s12879-019-3911-9
|
BMC Infect Dis |
2019 |
| A new oligonucleotide array for the detection of multidrug and extensively drug-resistance tuberculosis.
doi:10.1038/s41598-019-39339-3
|
Sci Rep |
2019 |
| Targeting DNA Gyrase to Combat Mycobacterium tuberculosis: An Update.
doi:10.2174/1568026619666190304130218
|
Curr Top Med Chem |
2019 |
| Effective therapeutic regimens in two South Asian countries with high resistance to major Helicobacter pylori antibiotics.
doi:10.1186/s13756-019-0482-x
|
Antimicrob Resist Infect Control |
2019 |
| Robustness of the Line Probe Assay for the Rapid Diagnosis and Characterization of Mutations in Extensively Drug-Resistant Tuberculosis.
doi:10.1089/mdr.2018.0268
|
Microb Drug Resist |
2019 |
| Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype-phenotype correlation.
doi:10.1186/s12941-018-0300-y
|
Ann Clin Microbiol Antimicrob |
2019 |
| Pharmacophore modeling and molecular dynamics approach to identify putative DNA Gyrase B inhibitors for resistant tuberculosis.
doi:10.1002/jcb.27579
|
J Cell Biochem |
2019 |
| Genetic Characterization of Second-Line Drug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis from the Northern Region of India.
doi:10.2991/j.jegh.2018.02.100
|
J Epidemiol Glob Health |
2018 |
| Chemical classes targeting energy supplying GyrB domain of Mycobacterium tuberculosis.
doi:10.1016/j.tube.2018.09.001
|
Tuberculosis (Edinb) |
2018 |
| Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis.
doi:10.1093/cid/ciy611
|
Clin Infect Dis |
2018 |
| Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis.
doi:10.2147/IDR.S178831
|
Infect Drug Resist |
2018 |
| A rapid and non-pathogenic assay for association of Mycobacterium tuberculosis gyrBA mutations and fluoroquinolone resistance using recombinant Mycobacterium smegmatis.
doi:10.1093/femsle/fny266
|
FEMS Microbiol Lett |
2018 |
| Evaluation of Genotype MTBDRplus and MTBDRsl Assays for Rapid Detection of Drug Resistance in Extensively Drug-Resistant Mycobacterium tuberculosis Isolates in Pakistan.
doi:10.3389/fmicb.2018.02265
|
Front Microbiol |
2018 |
| Evaluation of the GenoType MTBDRplus and MTBDRsl for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Beijing, China.
doi:10.2147/IDR.S176609
|
Infect Drug Resist |
2018 |
| Rewired Downregulation of DNA Gyrase Impacts Cell Division, Expression of Topology Modulators, and Transcription in Mycobacterium smegmatis.
doi:10.1016/j.jmb.2018.10.001
|
J Mol Biol |
2018 |
| A rapid identification technique for drug-resistant Mycobacterium tuberculosis isolates using mismatch specific cleavage enzyme.
doi:10.6026/97320630014404
|
Bioinformation |
2018 |
| In silico designing of domain B selective gyrase inhibitors for effective treatment of resistant tuberculosis.
doi:10.1016/j.tube.2018.08.005
|
Tuberculosis (Edinb) |
2018 |
| Whole-genome sequencing and single nucleotide polymorphisms in multidrug-resistant clinical isolates of Mycobacterium tuberculosis from the Philippines.
doi:10.1016/j.jgar.2018.08.009
|
J Glob Antimicrob Resist |
2018 |
| Pyrosequencing: a rapid and effective sequencing method to diagnose drug-resistant tuberculosis.
doi:10.1099/jmm.0.000669
|
J Med Microbiol |
2018 |
| Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting.
doi:10.1371/journal.pone.0200755
|
PLoS One |
2018 |
| Multi-center evaluation of GenoType MTBDRsl line probe assay for rapid detection of pre-XDR and XDR Mycobacterium tuberculosis in China.
doi:10.1016/j.jinf.2018.06.014
|
J Infect |
2018 |
| Association of gyrA and rrs gene mutations detected by MTBDRsl V1 on Mycobacterium tuberculosis strains of diverse genetic background from India.
doi:10.1038/s41598-018-27299-z
names it
|
Sci Rep |
2018 |
| Mutations in gyrA and gyrB in Moxifloxacin-Resistant Mycobacterium avium Complex and Mycobacterium abscessus Complex Clinical Isolates.
doi:10.1128/AAC.00527-18
names it
|
Antimicrob Agents Chemother |
2018 |
| Prospective study on antimicrobial resistance in leprosy cases diagnosed in France from 2001 to 2015.
doi:10.1016/j.cmi.2018.06.004
|
Clin Microbiol Infect |
2018 |
| Regulation of the gyr operon of Mycobacterium tuberculosis by overlapping promoters, DNA topology, and reiterative transcription.
doi:10.1016/j.bbrc.2018.05.067
|
Biochem Biophys Res Commun |
2018 |
| Single-nucleotide polymorphisms related to fluoroquinolone and aminoglycoside resistance in Mycobacterium avium isolates.
doi:10.2147/IDR.S160899
|
Infect Drug Resist |
2018 |
| Interaction between rpsL and gyrA mutations affects the fitness and dual resistance of Mycobacterium tuberculosis clinical isolates against streptomycin and fluoroquinolones.
doi:10.2147/IDR.S152335
names it
|
Infect Drug Resist |
2018 |
| Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
doi:10.3343/alm.2018.38.4.316
|
Ann Lab Med |
2018 |
| Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study.
doi:10.1016/S1473-3099(18)30073-2
|
Lancet Infect Dis |
2018 |
| Diagnostic accuracy of GenoType(®) MTBDRsl VER 2.0 in detecting second-line drug resistance to M. tuberculosis.
doi:10.5588/ijtld.17.0663
|
Int J Tuberc Lung Dis |
2018 |
| Resistance to anti leprosy drugs in multi-bacillary leprosy: A cross sectional study from a tertiary care centre in eastern Uttar Pradesh, India.
doi:10.4103/ijdvl.IJDVL_34_16
|
Indian J Dermatol Venereol Leprol |
2018 |
| Performance of Sequencing in Predicting Ofloxacin Resistance in Mycobacterium tuberculosis from Positive Bactec MGIT 960 Cultures.
|
Ann Clin Lab Sci |
2018 |
| Multi- and Extensively Drug Resistant Mycobacterium tuberculosis in South Africa: a Molecular Analysis of Historical Isolates.
doi:10.1128/JCM.01214-17
|
J Clin Microbiol |
2018 |
| Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case.
doi:10.2147/IDR.S152720
|
Infect Drug Resist |
2018 |
| Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15.
doi:10.1016/j.cmi.2018.02.022
|
Clin Microbiol Infect |
2018 |
| Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
doi:10.1186/s12879-018-3009-9
|
BMC Infect Dis |
2018 |
| Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii.
doi:10.1128/AAC.01788-17
|
Antimicrob Agents Chemother |
2018 |
| Genotypic detection of fluoroquinolone resistance in drug-resistant Mycobacterium tuberculosis at a tertiary care centre in south Coastal Karnataka, India.
doi:10.1016/j.jgar.2018.01.023
|
J Glob Antimicrob Resist |
2018 |
| Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
doi:10.5588/ijtld.17.0321
|
Int J Tuberc Lung Dis |
2018 |
| Molecular drug resistance profiles of Mycobacterium tuberculosis from sputum specimens using ion semiconductor sequencing.
doi:10.1016/j.mimet.2017.12.003
|
J Microbiol Methods |
2018 |
| Rapid Microarray-Based Detection of Rifampin, Isoniazid, and Fluoroquinolone Resistance in Mycobacterium tuberculosis by Use of a Single Cartridge.
doi:10.1128/JCM.01249-17
|
J Clin Microbiol |
2018 |
| Detection of resistance to fluoroquinolones and injectable drugs among antituberculosis drugs by allele-specific primer extension on a microsphere-based platform.
doi:10.1016/j.mimet.2017.11.007
|
J Microbiol Methods |
2018 |
| Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients.
doi:10.1016/j.jgar.2017.10.010
|
J Glob Antimicrob Resist |
2018 |
| Emerging resistant clones of Mycobacterium tuberculosis in a spatiotemporal context.
doi:10.1093/jac/dkx372
|
J Antimicrob Chemother |
2018 |
| In Vitro Activity and MIC of Sitafloxacin against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis Isolated in Thailand.
doi:10.1128/AAC.00825-17
|
Antimicrob Agents Chemother |
2018 |
| Characterization of gyrA and gyrB mutations associated with fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Morocco.
doi:10.1016/j.jgar.2017.10.003
names it
|
J Glob Antimicrob Resist |
2018 |
| Activity of 2-(quinolin-4-yloxy)acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing.
doi:10.1016/j.ijantimicag.2017.08.023
|
Int J Antimicrob Agents |
2018 |
| Characterization of Ofloxacin Interaction with Mutated (A91V) Quinolone Resistance Determining Region of DNA Gyrase in Mycobacterium Leprae through Computational Simulation.
doi:10.1007/s12013-017-0822-5
|
Cell Biochem Biophys |
2018 |
| Molecular detection of drug resistance to ofloxacin and kanamycin in Mycobacterium tuberculosis by using multiplex allele-specific PCR.
doi:10.1016/j.jiph.2017.03.007
|
J Infect Public Health |
2018 |
| Molecular characteristics of ofloxacin mono-resistant Mycobacterium tuberculosis isolates from new and previously treated tuberculosis patients.
doi:10.1002/jcla.22202
|
J Clin Lab Anal |
2018 |
| Natural environmental water sources in endemic regions of northeastern Brazil are potential reservoirs of viable Mycobacterium leprae.
doi:10.1590/0074-02760170117
|
Mem Inst Oswaldo Cruz |
2017 |
| Mutation analysis for detection of drug resistance in mycobacterium tuberculosis isolates from Khyber Pakhtunkhwa, Pakistan.
|
J Pak Med Assoc |
2017 |
| Applied multiplex allele specific PCR to detect second-line drug resistance among multidrug-resistant tuberculosis in China.
doi:10.1016/j.tube.2017.07.010
|
Tuberculosis (Edinb) |
2017 |
| Fluoroquinolone Resistance Mutation Detection Is Equivalent to Culture-Based Drug Sensitivity Testing for Predicting Multidrug-Resistant Tuberculosis Treatment Outcome: A Retrospective Cohort Study.
doi:10.1093/cid/cix556
|
Clin Infect Dis |
2017 |
| Whole-genome sequencing illuminates the evolution and spread of multidrug-resistant tuberculosis in Southwest Nigeria.
doi:10.1371/journal.pone.0184510
|
PLoS One |
2017 |
| Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
doi:10.1056/NEJMoa1614915
|
N Engl J Med |
2017 |
| [The Spectrum of Mutations in Genes Associated with Resistance to Rifampicin, Isoniazid, and Fluoroquinolones in the Clinical Strains of M. tuberculosis Reflects the Transmissibility of Mutant Clones].
doi:10.7868/S0026898417030041
|
Mol Biol (Mosk) |
2017 |
| Mycobacterium tuberculosis Subculture Results in Loss of Potentially Clinically Relevant Heteroresistance.
doi:10.1128/AAC.00888-17
|
Antimicrob Agents Chemother |
2017 |
| Prevalence and Molecular Characterization of Second-Line Drugs Resistance among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Southwest of China.
doi:10.1155/2017/4563826
|
Biomed Res Int |
2017 |
| In Silico Prediction of Antibiotic Resistance in Mycobacterium ulcerans Agy99 through Whole Genome Sequence Analysis.
doi:10.4269/ajtmh.16-0478
|
Am J Trop Med Hyg |
2017 |
| In Vitro Drug Susceptibility of Bedaquiline, Delamanid, Linezolid, Clofazimine, Moxifloxacin, and Gatifloxacin against Extensively Drug-Resistant Tuberculosis in Beijing, China.
doi:10.1128/AAC.00900-17
|
Antimicrob Agents Chemother |
2017 |
| A comparative study of phenotypic and genotypic first- and second-line drug resistance testing of Mycobacterium tuberculosis.
doi:10.1016/j.biologicals.2017.07.003
|
Biologicals |
2017 |
| High incidence of fluoroquinolone resistance and effect of efflux pump inhibitors on moxifloxacin resistance among Mycobacterium tuberculosis isolates causing urinary tract infection in Taiwan.
doi:10.1016/j.ijantimicag.2017.04.010
|
Int J Antimicrob Agents |
2017 |
| Impact of gyrB and eis Mutations in Improving Detection of Second-Line-Drug Resistance among Mycobacterium tuberculosis Isolates from Georgia.
doi:10.1128/AAC.01921-16
|
Antimicrob Agents Chemother |
2017 |
| In vitro activity of sitafloxacin against Mycobacterium tuberculosis with gyrA/B mutations isolated in Japan.
doi:10.1099/jmm.0.000493
names it
|
J Med Microbiol |
2017 |
| qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients.
doi:10.1371/journal.pntd.0005506
|
PLoS Negl Trop Dis |
2017 |
| Prevalence and extent of heteroresistance by next generation sequencing of multidrug-resistant tuberculosis.
doi:10.1371/journal.pone.0176522
|
PLoS One |
2017 |
| Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis?
doi:10.1093/jac/dkx150
|
J Antimicrob Chemother |
2017 |
| Diagnostic performance of Anyplex II MTB/MDR/XDR for detection of resistance to first and second line drugs in Mycobacterium tuberculosis.
doi:10.1016/j.mimet.2017.05.006
|
J Microbiol Methods |
2017 |
| First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant Mycobacterium tuberculosis in Saudi Arabia.
doi:10.4269/ajtmh.16-0579
|
Am J Trop Med Hyg |
2017 |
| Performance of TaqMan array card to detect TB drug resistance on direct specimens.
doi:10.1371/journal.pone.0177167
|
PLoS One |
2017 |
| Expression, purification, and characterization of recombinant 8 kDa gelsolin fragment.
doi:10.1016/j.pep.2017.04.016
|
Protein Expr Purif |
2017 |
| Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
doi:10.1186/s12879-017-2409-6
|
BMC Infect Dis |
2017 |
| Increased Tuberculosis Patient Mortality Associated with Mycobacterium tuberculosis Mutations Conferring Resistance to Second-Line Antituberculous Drugs.
doi:10.1128/JCM.00152-17
|
J Clin Microbiol |
2017 |
| Double mutation in DNA gyrase confers moxifloxacin resistance and decreased fitness of Mycobacterium smegmatis.
doi:10.1093/jac/dkx110
|
J Antimicrob Chemother |
2017 |
| Double Mutants in DNA Gyrase Lead to Ofloxacin Resistance in Mycobacterium tuberculosis.
doi:10.1002/jcb.25954
|
J Cell Biochem |
2017 |
| Antituberculosis Drug Resistance in Pulmonary Isolates of Mycobacterium tuberculosis, Cuba 2012-2014.
doi:10.37757/MR2017.V19.N1.3
|
MEDICC Rev |
2017 |
| Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria.
doi:10.1128/AAC.02100-16
|
Antimicrob Agents Chemother |
2017 |
| Some Synonymous and Nonsynonymous gyrA Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDRsl Assays.
doi:10.1128/AAC.02169-16
names it
|
Antimicrob Agents Chemother |
2017 |
| FIND Tuberculosis Strain Bank: a Resource for Researchers and Developers Working on Tests To Detect Mycobacterium tuberculosis and Related Drug Resistance.
doi:10.1128/JCM.01662-16
|
J Clin Microbiol |
2017 |
| Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China.
doi:10.1371/journal.pone.0169413
|
PLoS One |
2017 |
| pncA mutations are associated with slower sputum conversion during standard treatment of multidrug-resistant tuberculosis.
doi:10.1016/j.ijantimicag.2016.10.012
|
Int J Antimicrob Agents |
2017 |
| Evaluation of the GenoType MTBDRsl Version 2.0 Assay for Second-Line Drug Resistance Detection of Mycobacterium tuberculosis Isolates in South Africa.
doi:10.1128/JCM.01865-16
|
J Clin Microbiol |
2017 |
| De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro.
doi:10.1128/AAC.01343-16
|
Antimicrob Agents Chemother |
2017 |
| Detection of Isoniazid-, Fluoroquinolone-, Amikacin-, and Kanamycin-Resistant Tuberculosis in an Automated, Multiplexed 10-Color Assay Suitable for Point-of-Care Use.
doi:10.1128/JCM.01771-16
|
J Clin Microbiol |
2017 |
| Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from high prevalence tuberculosis states in Mexico.
doi:10.1016/j.meegid.2016.09.012
|
Infect Genet Evol |
2017 |
| Insights into Pyrazinamidase and DNA Gyrase Protein Structures in Resistant and Susceptible Clinical Isolates of Mycobacterium tuberculosis.
|
Tanaffos |
2016 |
| Impact of genotypic and phenotypic resistance to second-line anti-tuberculosis drugs on treatment outcomes in multidrug-resistant tuberculosis in China.
doi:10.1016/j.ijmyco.2016.11.007
|
Int J Mycobacteriol |
2016 |
| Molecular drug susceptibility testing against the first-line (rifampin and isoniazid) and second-line (ciprofloxacin-amikacin and kanamycin) treatment in different subtypes of Mycobacterium simiae.
doi:10.1016/j.ijmyco.2016.11.006
|
Int J Mycobacteriol |
2016 |
| A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, Russia.
doi:10.1371/journal.pone.0167093
|
PLoS One |
2016 |
| Molecular detection of fluoroquinolone resistance-associated gyrA mutations in ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Iran and Belarus.
doi:10.1016/j.ijmyco.2016.07.004
names it
|
Int J Mycobacteriol |
2016 |
| Performance of the GenoType MTBDRplus assay (v2.0) and a new extended GenoType MTBDRsl assay (v2.0) for the molecular detection of multi- and extensively drug-resistant Mycobacterium tuberculosis on isolates primarily from Lithuania.
doi:10.1016/j.diagmicrobio.2016.08.026
|
Diagn Microbiol Infect Dis |
2016 |
| Mutations in the drug resistance-determining region of Mycobacterium lepromatosis isolated from leprosy patients in Mexico.
doi:10.1111/1346-8138.13483
|
J Dermatol |
2016 |
| Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
doi:10.1371/journal.pntd.0005041
|
PLoS Negl Trop Dis |
2016 |
| In vivo Mycobacterium tuberculosis fluoroquinolone resistance emergence: a complex phenomenon poorly detected by current diagnostic tests.
doi:10.1093/jac/dkw344
|
J Antimicrob Chemother |
2016 |
| A Case of Fluoroquinolone-Resistant Leprosy Discovered after 9 Years of Misdiagnosis.
doi:10.1155/2016/4632369
|
Case Rep Infect Dis |
2016 |
| Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis.
doi:10.1186/s12879-016-1781-y
|
BMC Infect Dis |
2016 |
| Genomic Analysis of the Evolution of Fluoroquinolone Resistance in Mycobacterium tuberculosis Prior to Tuberculosis Diagnosis.
doi:10.1128/AAC.00664-16
|
Antimicrob Agents Chemother |
2016 |
| Sequence Analysis of Fluoroquinolone Resistance-Associated Genes gyrA and gyrB in Clinical Mycobacterium tuberculosis Isolates from Patients Suspected of Having Multidrug-Resistant Tuberculosis in New Delhi, India.
doi:10.1128/JCM.00670-16
names it
|
J Clin Microbiol |
2016 |
| Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin.
doi:10.1128/AAC.00393-16
|
Antimicrob Agents Chemother |
2016 |
| Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
doi:10.1128/AAC.00539-16
|
Antimicrob Agents Chemother |
2016 |
| Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis.
doi:10.1093/jac/dkw169
names it
|
J Antimicrob Chemother |
2016 |
| Analysis of DNA gyrA Gene Mutation in Clinical and Environmental Ciprofloxacin-Resistant Isolates of Non-Tuberculous Mycobacteria Using Molecular Methods.
doi:10.5812/jjm.30018
names it
|
Jundishapur J Microbiol |
2016 |
| Moxifloxacin Improves Treatment Outcomes in Patients with Ofloxacin-Resistant Multidrug-Resistant Tuberculosis.
doi:10.1128/AAC.00425-16
|
Antimicrob Agents Chemother |
2016 |
| Clinical Features and Drug-Resistance Profile of Urinary Tuberculosis in South-Western China: A Cross-sectional Study.
doi:10.1097/MD.0000000000003537
|
Medicine (Baltimore) |
2016 |
| Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape.
doi:10.1128/AAC.00222-16
|
Antimicrob Agents Chemother |
2016 |
| Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains.
doi:10.1128/JCM.00051-16
|
J Clin Microbiol |
2016 |
| Simultaneous drug resistance detection and genotyping of Mycobacterium tuberculosis using a low-density hydrogel microarray.
doi:10.1093/jac/dkw015
|
J Antimicrob Chemother |
2016 |
| Impact of mutations in DNA gyrase genes on quinolone resistance in Campylobacter jejuni.
doi:10.1002/dta.1937
|
Drug Test Anal |
2016 |
| Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in Mycobacterium tuberculosis.
doi:10.1093/jac/dkv499
|
J Antimicrob Chemother |
2016 |
| A molecular platform for the diagnosis of multidrug-resistant and pre-extensively drug-resistant tuberculosis based on single nucleotide polymorphism mutations present in Colombian isolates of Mycobacterium tuberculosis.
doi:10.1590/0074-02760150306
|
Mem Inst Oswaldo Cruz |
2016 |
| Molecular Analysis of Sarcoidosis Granulomas Reveals Antimicrobial Targets.
doi:10.1165/rcmb.2015-0212OC
|
Am J Respir Cell Mol Biol |
2016 |
| Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase.
doi:10.1073/pnas.1525055113
|
Proc Natl Acad Sci U S A |
2016 |
| Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates.
doi:10.1128/AAC.01049-15
names it
|
Antimicrob Agents Chemother |
2016 |
| Gyrase Mutations Are Associated with Variable Levels of Fluoroquinolone Resistance in Mycobacterium tuberculosis.
doi:10.1128/JCM.02775-15
|
J Clin Microbiol |
2016 |
| Subspecies distribution and macrolide and fluoroquinolone resistance genetics of Mycobacterium abscessus in Korea.
doi:10.5588/ijtld.15.0068
|
Int J Tuberc Lung Dis |
2016 |
| Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement.
doi:10.5588/ijtld.15.0221
|
Int J Tuberc Lung Dis |
2016 |
| Replacement of cardiotoxic aminopiperidine linker with piperazine moiety reduces cardiotoxicity? Mycobacterium tuberculosis novel bacterial topoisomerase inhibitors.
doi:10.1016/j.bmc.2015.11.039
|
Bioorg Med Chem |
2016 |
| Specific gyrA gene mutations predict poor treatment outcome in MDR-TB.
doi:10.1093/jac/dkv360
names it
|
J Antimicrob Chemother |
2016 |
| Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB.
doi:10.1093/jac/dkv353
names it
|
J Antimicrob Chemother |
2016 |
| Prevalence of mutations conferring resistance among multi- and extensively drug-resistant Mycobacterium tuberculosis isolates in China.
doi:10.1038/ja.2015.106
|
J Antibiot (Tokyo) |
2016 |
| Engineering versatile protein expression systems mediated by inteins in Escherichia coli.
doi:10.1007/s00253-015-6960-z
|
Appl Microbiol Biotechnol |
2016 |
| Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
doi:10.1016/j.jmii.2015.04.003
|
J Microbiol Immunol Infect |
2016 |
| [Detection of mutations in the gyrA and gyrB genes associated with fluoroquinolone-resistance among clinical isolates of Mycobacterium abscessus in China].
names it
|
Zhonghua Jie He He Hu Xi Za Zhi |
2015 |
| Genome sequence comparisons of serial multi-drug-resistant Mycobacterium tuberculosis isolates over 21 years of infection in a single patient.
doi:10.1099/mgen.0.000037
|
Microb Genom |
2015 |
| Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations.
doi:10.5588/ijtld.14.0277
names it
|
Int J Tuberc Lung Dis |
2015 |
| Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
doi:10.1371/journal.pmed.1001880
|
PLoS Med |
2015 |
| Identification of chebulinic acid as potent natural inhibitor of M. tuberculosis DNA gyrase and molecular insights into its binding mode of action.
doi:10.1016/j.compbiolchem.2015.09.006
|
Comput Biol Chem |
2015 |
| Pyrosequencing for rapid detection of Mycobacterium tuberculosis second-line drugs and ethambutol resistance.
doi:10.1016/j.diagmicrobio.2015.07.004
|
Diagn Microbiol Infect Dis |
2015 |
| Proteomic analysis of ofloxacin-mono resistant Mycobacterium tuberculosis isolates.
doi:10.1016/j.jprot.2015.07.031
|
J Proteomics |
2015 |
| Correlation between GyrA substitutions and ofloxacin, levofloxacin, and moxifloxacin cross-resistance in Mycobacterium tuberculosis.
doi:10.1128/AAC.00662-15
names it
|
Antimicrob Agents Chemother |
2015 |
| Drug resistance in Mycobacterium leprae from patients with leprosy in China.
doi:10.1111/ced.12665
|
Clin Exp Dermatol |
2015 |
| Comparative Evaluation of Sloppy Molecular Beacon and Dual-Labeled Probe Melting Temperature Assays to Identify Mutations in Mycobacterium tuberculosis Resulting in Rifampin, Fluoroquinolone and Aminoglycoside Resistance.
doi:10.1371/journal.pone.0126257
|
PLoS One |
2015 |
| Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.
doi:10.1371/journal.pone.0120470
names it
|
PLoS One |
2015 |
| Fluoroquinolones for the treatment of tuberculosis in children.
doi:10.1016/j.tube.2015.02.037
|
Tuberculosis (Edinb) |
2015 |
| Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan.
doi:10.1371/journal.pone.0117771
|
PLoS One |
2015 |
| Integrated microfluidic card with TaqMan probes and high-resolution melt analysis to detect tuberculosis drug resistance mutations across 10 genes.
doi:10.1128/mBio.02273-14
|
mBio |
2015 |
| Low resistance to first and second line anti-tuberculosis drugs among treatment naive pulmonary tuberculosis patients in southwestern Uganda.
doi:10.1371/journal.pone.0118191
|
PLoS One |
2015 |
| Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis.
doi:10.1128/AAC.04058-14
|
Antimicrob Agents Chemother |
2015 |
| Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay.
doi:10.1016/j.tube.2014.11.003
names it
|
Tuberculosis (Edinb) |
2015 |
| Comparative analysis of the effectiveness of C-terminal cleavage intein-based constructs in producing a recombinant analog of anophelin, an anticoagulant from Anopheles albimanus.
doi:10.1007/s12010-014-1400-6
|
Appl Biochem Biotechnol |
2015 |
| Molecular characterisation of extensively drug-resistant Mycobacterium tuberculosis isolates in China.
doi:10.1016/j.ijantimicag.2014.09.018
|
Int J Antimicrob Agents |
2015 |
| Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries.
doi:10.1128/AAC.03614-14
|
Antimicrob Agents Chemother |
2015 |
| Assays, surrogates, and alternative technologies for a TB lead identification program targeting DNA gyrase ATPase.
doi:10.1177/1087057114554170
|
J Biomol Screen |
2015 |
| Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin.
doi:10.1038/ja.2014.95
names it
|
J Antibiot (Tokyo) |
2015 |
| The Molecular Genetics of Fluoroquinolone Resistance in Mycobacterium tuberculosis.
doi:10.1128/microbiolspec.MGM2-0009-2013
|
Microbiol Spectr |
2014 |
| [Analysis of genetic determinants of multidrug and extensively drug-resistant Mycobacterium tuberculosis using oligonucleotide microchip].
|
Mol Biol (Mosk) |
2014 |
| [Resistance to second-line anti-tuberculosis drugs among peruvian multidrug resistant Mycobacterium tuberculosis strains].
|
Rev Peru Med Exp Salud Publica |
2014 |
| [Conventional and molecular diagnosis in a group of patients with drug-resistant tuberculosis].
|
Pneumologia |
2014 |
| Identification of primary drug resistance to rifampin in Mycobacterium leprae strains from leprosy patients in Amazonas State, Brazil.
doi:10.1128/JCM.01688-14
|
J Clin Microbiol |
2014 |
| Quinolone-containing therapies in the eradication of Helicobacter pylori.
doi:10.1155/2014/151543
|
Biomed Res Int |
2014 |
| Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis.
doi:10.2147/IDR.S65417
|
Infect Drug Resist |
2014 |
| Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.
doi:10.1186/1471-2334-14-478
|
BMC Infect Dis |
2014 |
| [Rapid detection of mutations related to Mycobacterium leprae drug resistance by using Hp-rPCR (hairpin primer- real time PCR) method].
doi:10.5025/hansen.83.6
|
Nihon Hansenbyo Gakkai Zasshi |
2014 |
| Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China.
doi:10.1111/tmi.12359
|
Trop Med Int Health |
2014 |
| [Heteroresistance in Mycobacteria tuberculosis is an important factor for the inconsistency between the results of phenotype and genotype drug susceptibility tests].
|
Zhonghua Jie He He Hu Xi Za Zhi |
2014 |
| [Induction in vitro and stability of Mycobacterium tuberculosis resistance to ofloxacin].
|
Zhonghua Yu Fang Yi Xue Za Zhi |
2014 |
| Ofloxacin resistance in Mycobacterium tuberculosis is associated with efflux pump activity independent of resistance pattern and genotype.
doi:10.1089/mdr.2013.0171
|
Microb Drug Resist |
2014 |
| Pseudo-outbreak of pre-extensively drug-resistant (Pre-XDR) tuberculosis in Kinshasa: collateral damage caused by false detection of fluoroquinolone resistance by GenoType MTBDRsl.
doi:10.1128/JCM.00398-14
|
J Clin Microbiol |
2014 |
| Mechanisms of fluoroquinolone monoresistance in Mycobacterium tuberculosis.
doi:10.1111/1574-6968.12401
|
FEMS Microbiol Lett |
2014 |
| Prediction of XDR/pre-XDR tuberculosis by genetic mutations among MDR cases from a hospital in Shandong, China.
doi:10.1016/j.tube.2014.03.005
|
Tuberculosis (Edinb) |
2014 |
| First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA.
doi:10.1371/journal.pone.0095083
names it
|
PLoS One |
2014 |
| Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Hunan, China.
doi:10.1128/AAC.02426-14
|
Antimicrob Agents Chemother |
2014 |
| MUBII-TB-DB: a database of mutations associated with antibiotic resistance in Mycobacterium tuberculosis.
doi:10.1186/1471-2105-15-107
|
BMC Bioinformatics |
2014 |
| Pyrosequencing for rapid detection of tuberculosis resistance in clinical isolates and sputum samples from re-treatment pulmonary tuberculosis patients.
doi:10.1186/1471-2334-14-200
|
BMC Infect Dis |
2014 |
| High proportion of heteroresistance in gyrA and gyrB in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.
doi:10.1128/AAC.02066-13
names it
|
Antimicrob Agents Chemother |
2014 |
| Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis.
doi:10.1038/emi.2014.21
names it
|
Emerg Microbes Infect |
2014 |
| Molecular characterization of Mycobacterium tuberculosis isolates from elephants of Nepal.
doi:10.1016/j.tube.2013.12.008
|
Tuberculosis (Edinb) |
2014 |
| Moxifloxacin retains antimycobacterial activity in the presence of gyrA mutations.
doi:10.1128/AAC.02583-13
names it
|
Antimicrob Agents Chemother |
2014 |
| Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding.
doi:10.1074/jbc.M113.529164
|
J Biol Chem |
2014 |
| Molecular basis for the differential quinolone susceptibility of mycobacterial DNA gyrase.
doi:10.1128/AAC.01958-13
|
Antimicrob Agents Chemother |
2014 |
| Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China.
doi:10.1128/AAC.01792-13
|
Antimicrob Agents Chemother |
2014 |
| Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations.
doi:10.1128/JCM.02701-13
|
J Clin Microbiol |
2014 |
| Prevalence and molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates in China.
doi:10.1128/AAC.01228-13
|
Antimicrob Agents Chemother |
2014 |
| Systematic review of allelic exchange experiments aimed at identifying mutations that confer drug resistance in Mycobacterium tuberculosis.
doi:10.1093/jac/dkt358
|
J Antimicrob Chemother |
2014 |
| Geographical differences associated with single-nucleotide polymorphisms (SNPs) in nine gene targets among resistant clinical isolates of Mycobacterium tuberculosis.
doi:10.1128/JCM.00857-13
|
J Clin Microbiol |
2014 |
| Inhibition of the Mycobacterium tuberculosis reserpine-sensitive efflux pump augments intracellular concentrations of ciprofloxacin and enhances susceptibility of some clinical isolates.
doi:10.1016/j.jfma.2012.03.009
|
J Formos Med Assoc |
2013 |
| Resistance of M. leprae to quinolones: a question of relativity?
doi:10.1371/journal.pntd.0002559
|
PLoS Negl Trop Dis |
2013 |
| Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania.
doi:10.1186/1471-2334-13-432
|
BMC Infect Dis |
2013 |
| Rapid detection of drug resistance and mutational patterns of extensively drug-resistant strains by a novel GenoType® MTBDRsl assay.
doi:10.4103/0022-3859.118034
|
J Postgrad Med |
2013 |
| Detection of streptomycin and quinolone resistance in Mycobacterium tuberculosis by a low-density DNA array.
doi:10.1016/j.tube.2013.07.001
|
Tuberculosis (Edinb) |
2013 |
| Mycobacterium tuberculosis DNA gyrase possesses two functional GyrA-boxes.
doi:10.1042/BJ20130430
names it
|
Biochem J |
2013 |
| Identification of the likely translational start of Mycobacterium tuberculosis GyrB.
doi:10.1186/1756-0500-6-274
|
BMC Res Notes |
2013 |
| Impact of fluoroquinolone resistance on bactericidal and sterilizing activity of a moxifloxacin-containing regimen in murine tuberculosis.
doi:10.1128/AAC.00506-13
|
Antimicrob Agents Chemother |
2013 |
| Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.
doi:10.5588/ijtld.12.0949
|
Int J Tuberc Lung Dis |
2013 |
| Fluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to older- versus newer-generation fluoroquinolones.
doi:10.1016/j.ijantimicag.2013.04.027
|
Int J Antimicrob Agents |
2013 |
| Determination of critical concentrations of moxifloxacin and gatifloxacin for drug susceptibility testing of Mycobacterium tuberculosis in the BACTEC MGIT 960 system.
doi:10.1093/jac/dkt202
|
J Antimicrob Chemother |
2013 |
| Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China.
doi:10.1128/AAC.00102-13
|
Antimicrob Agents Chemother |
2013 |
| Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays.
doi:10.1186/1471-2334-13-240
|
BMC Infect Dis |
2013 |
| Clinical isolates of Mycobacterium abscessus in Guangzhou area most possibly from the environmental infection showed variable susceptibility.
|
Chin Med J (Engl) |
2013 |
| Predictive value of molecular drug resistance testing of Mycobacterium tuberculosis isolates in Valle del Cauca, Colombia.
doi:10.1128/JCM.00429-13
|
J Clin Microbiol |
2013 |
| Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
doi:10.1016/j.diagmicrobio.2013.02.035
|
Diagn Microbiol Infect Dis |
2013 |
| Characterization of multiple and extensively drug resistant Mycobacterium tuberculosis isolates with different ofloxacin-resistance levels.
doi:10.1016/j.tube.2013.02.005
|
Tuberculosis (Edinb) |
2013 |
| Digital PCR to detect and quantify heteroresistance in drug resistant Mycobacterium tuberculosis.
doi:10.1371/journal.pone.0057238
|
PLoS One |
2013 |
| Mycobacterium leprae in Colombia described by SNP7614 in gyrA, two minisatellites and geography.
doi:10.1016/j.meegid.2012.12.015
names it
|
Infect Genet Evol |
2013 |
| Triplex real-time PCR melting curve analysis for detecting Mycobacterium tuberculosis mutations associated with resistance to second-line drugs in a single reaction.
doi:10.1093/jac/dks509
|
J Antimicrob Chemother |
2013 |
| Characterization of extensively drug-resistant Mycobacterium tuberculosis in Nepal.
doi:10.1016/j.tube.2012.10.007
|
Tuberculosis (Edinb) |
2013 |
| From multidrug-resistant to extensively drug-resistant tuberculosis in Lisbon, Portugal: the stepwise mode of resistance acquisition.
doi:10.1093/jac/dks371
|
J Antimicrob Chemother |
2013 |
| Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin.
doi:10.1099/jmm.0.046821-0
names it
|
J Med Microbiol |
2013 |
| [Evaluation of GenoType MTBDRsl for testing resistance of Mycobacterium tuberculosis isolates to fluoroquinlone, aminoglycoside, and ethambutol].
|
Kekkaku |
2012 |
| Rapid identification of extensively and extremely drug resistant tuberculosis from multidrug resistant strains; using PCR-RFLP and PCR-SSCP.
|
Iran J Microbiol |
2012 |
| Impact of amino acid substitutions in B subunit of DNA gyrase in Mycobacterium leprae on fluoroquinolone resistance.
doi:10.1371/journal.pntd.0001838
|
PLoS Negl Trop Dis |
2012 |
| Heterogeneity of Mycobacterium tuberculosis strains in Makassar, Indonesia.
doi:10.5588/ijtld.12.0055
|
Int J Tuberc Lung Dis |
2012 |
| Binding of two DNA molecules by type II topoisomerases for decatenation.
doi:10.1093/nar/gks843
|
Nucleic Acids Res |
2012 |
| Next-generation ion torrent sequencing of drug resistance mutations in Mycobacterium tuberculosis strains.
doi:10.1128/JCM.01893-12
|
J Clin Microbiol |
2012 |
| Drug resistance-related mutations in multidrug-resistant Mycobacterium tuberculosis isolates from diverse geographical regions.
doi:10.1016/j.ijmyco.2012.08.001
|
Int J Mycobacteriol |
2012 |
| Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test.
doi:10.1371/journal.pntd.0001739
|
PLoS Negl Trop Dis |
2012 |
| The role of Ca²⁺ in the activity of Mycobacterium tuberculosis DNA gyrase.
doi:10.1093/nar/gks704
|
Nucleic Acids Res |
2012 |
| New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations.
doi:10.1371/journal.pone.0039754
names it
|
PLoS One |
2012 |
| 'Z(S)-MDR-TB' versus 'Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility.
doi:10.1038/emi.2012.18
|
Emerg Microbes Infect |
2012 |
| Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
doi:10.1016/j.diagmicrobio.2012.03.025
|
Diagn Microbiol Infect Dis |
2012 |
| Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China.
doi:10.1128/JCM.06860-11
|
J Clin Microbiol |
2012 |
| Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China.
doi:10.1016/s1413-8670(12)70294-5
names it
|
Braz J Infect Dis |
2012 |
| gyrA/B fluoroquinolone resistance allele profiles amongst Mycobacterium tuberculosis isolates from mainland China.
doi:10.1016/j.ijantimicag.2012.02.015
names it
|
Int J Antimicrob Agents |
2012 |
| Low rates of synonymous mutations in sequences of Mycobacterium tuberculosis GyrA and KatG genes.
doi:10.1016/j.tube.2012.03.004
names it
|
Tuberculosis (Edinb) |
2012 |
| Drug and multidrug resistance among Mycobacterium leprae isolates from Brazilian relapsed leprosy patients.
doi:10.1128/JCM.06561-11
|
J Clin Microbiol |
2012 |
| Detection of first- and second-line drug resistance in Mycobacterium tuberculosis clinical isolates by pyrosequencing.
doi:10.1128/JCM.06664-11
|
J Clin Microbiol |
2012 |
| Mechanisms for defining supercoiling set point of DNA gyrase orthologs: II. The shape of the GyrA subunit C-terminal domain (CTD) is not a sole determinant for controlling supercoiling efficiency.
doi:10.1074/jbc.M112.345736
names it
|
J Biol Chem |
2012 |
| Sensitivities of ciprofloxacin-resistant Mycobacterium tuberculosis clinical isolates to fluoroquinolones: role of mutant DNA gyrase subunits in drug resistance.
doi:10.1016/j.ijantimicag.2012.01.007
|
Int J Antimicrob Agents |
2012 |
| High-resolution melting analysis for the rapid detection of fluoroquinolone and streptomycin resistance in Mycobacterium tuberculosis.
doi:10.1371/journal.pone.0031934
|
PLoS One |
2012 |
| gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis.
doi:10.1093/jac/dks033
names it
|
J Antimicrob Chemother |
2012 |
| Multiplex allele specific PCR for rapid detection of extensively drug resistant tuberculosis.
doi:10.1016/j.tube.2012.01.004
|
Tuberculosis (Edinb) |
2012 |
| Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing.
doi:10.1128/AAC.05905-11
|
Antimicrob Agents Chemother |
2012 |
| Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis.
doi:10.1128/AAC.06272-11
|
Antimicrob Agents Chemother |
2012 |
| A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.
doi:10.1093/jac/dkr566
|
J Antimicrob Chemother |
2012 |
| Influence of lineage-specific amino acid dimorphisms in GyrA on Mycobacterium tuberculosis resistance to fluoroquinolones.
names it
|
Jpn J Infect Dis |
2012 |
| Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.
doi:10.5588/ijtld.10.0600
|
Int J Tuberc Lung Dis |
2012 |
| The TDR Tuberculosis Strain Bank: a resource for basic science, tool development and diagnostic services.
doi:10.5588/ijtld.11.0223
|
Int J Tuberc Lung Dis |
2012 |
| High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility.
doi:10.1128/JCM.05286-11
names it
|
J Clin Microbiol |
2012 |
| Real-time PCR and high-resolution melt analysis for rapid detection of Mycobacterium leprae drug resistance mutations and strain types.
doi:10.1128/JCM.05183-11
|
J Clin Microbiol |
2012 |
| Multiplex allele-specific PCR combined with PCR-RFLP analysis for rapid detection of gyrA gene fluoroquinolone resistance mutations in Mycobacterium tuberculosis.
doi:10.1016/j.mimet.2011.10.015
names it
|
J Microbiol Methods |
2012 |
| Amino acid substitutions at position 95 in GyrA can add fluoroquinolone resistance to Mycobacterium leprae.
doi:10.1128/AAC.05890-11
names it
|
Antimicrob Agents Chemother |
2012 |
| Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis.
doi:10.1093/jac/dkr449
|
J Antimicrob Chemother |
2012 |
| Phenotypic and molecular characterization of quinolone resistance in Mycobacterium abscessus subsp. bolletii recovered from postsurgical infections.
doi:10.1099/jmm.0.034942-0
|
J Med Microbiol |
2012 |
| gyrA and gyrB gene mutation in ciprofloxacin-resistant Mycobacterium massiliense clinical isolates from Southern Brazil.
doi:10.1089/mdr.2011.0047
names it
|
Microb Drug Resist |
2012 |
| gyrA and gyrB mutations in ofloxacin-resistant Mycobacterium tuberculosis clinical isolates in Thailand.
names it
|
Southeast Asian J Trop Med Public Health |
2011 |
| Docking studies on novel analogues of 8 methoxy fluoroquinolones against GyrA mutants of Mycobacterium tuberculosis.
doi:10.1186/1472-6807-11-47
names it
|
BMC Struct Biol |
2011 |
| Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes.
doi:10.1186/1471-2334-11-255
|
BMC Infect Dis |
2011 |
| Characterization of mutations conferring extensive drug resistance to Mycobacterium tuberculosis isolates in Pakistan.
doi:10.1128/AAC.05101-11
|
Antimicrob Agents Chemother |
2011 |
| Rapid detection of isoniazid, rifampin, and ofloxacin resistance in Mycobacterium tuberculosis clinical isolates using high-resolution melting analysis.
doi:10.1128/JCM.01068-11
|
J Clin Microbiol |
2011 |
| DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.
doi:10.1128/AAC.00707-11
|
Antimicrob Agents Chemother |
2011 |
| The dimer state of GyrB is an active form: implications for the initial complex assembly and processive strand passage.
doi:10.1093/nar/gkr553
|
Nucleic Acids Res |
2011 |
| Survival of civilian and prisoner drug-sensitive, multi- and extensive drug- resistant tuberculosis cohorts prospectively followed in Russia.
doi:10.1371/journal.pone.0020531
|
PLoS One |
2011 |
| Extending the scope of site-specific cysteine bioconjugation by appending a prelabeled cysteine tag to proteins using protein trans-splicing.
doi:10.1007/978-1-61779-151-2_9
|
Methods Mol Biol |
2011 |
| Incidence of moxifloxacin resistance in clinical Mycobacterium tuberculosis isolates in Houston, Texas.
doi:10.1128/JCM.00231-11
|
J Clin Microbiol |
2011 |
| Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance.
doi:10.1128/AAC.00042-11
|
Antimicrob Agents Chemother |
2011 |
| Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
names it
|
Lepr Rev |
2011 |
| Evaluation of two molecular assays for rapid detection of mycobacterium tuberculosis resistance to fluoroquinolones in high-tuberculosis and -multidrug-resistance Settings.
doi:10.1128/JCM.01889-10
|
J Clin Microbiol |
2011 |
| Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates.
|
Indian J Med Res |
2011 |
| Genotyping of Mycobacterium leprae from Brazilian leprosy patients suggests the occurrence of reinfection or of bacterial population shift during disease relapse.
doi:10.1099/jmm.0.029389-0
|
J Med Microbiol |
2011 |
| Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis.
doi:10.1128/JCM.00197-11
|
J Clin Microbiol |
2011 |
| Characteristic resistance mechanism of Mycobacterium tuberculosis to DC-159a, a new respiratory quinolone.
doi:10.1128/AAC.00417-10
|
Antimicrob Agents Chemother |
2011 |
| First report of molecular detection of fluoroquinolone resistance-associated gyrA mutations in multidrug-resistant clinical Mycobacterium tuberculosis isolates in Kuwait.
doi:10.1186/1756-0500-4-123
names it
|
BMC Res Notes |
2011 |
| Population-based investigation of fluoroquinolones resistant tuberculosis in rural eastern China.
doi:10.1016/j.tube.2011.03.001
|
Tuberculosis (Edinb) |
2011 |
| Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009.
doi:10.1186/1471-2334-11-78
names it
|
BMC Infect Dis |
2011 |
| Fluoroquinolone and quinazolinedione activities against wild-type and gyrase mutant strains of Mycobacterium smegmatis.
doi:10.1128/AAC.00033-11
|
Antimicrob Agents Chemother |
2011 |
| Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
doi:10.1128/AAC.01550-10
|
Antimicrob Agents Chemother |
2011 |
| Analysis of drug-resistant strains of Mycobacterium leprae in an endemic area of Vietnam.
doi:10.1093/cid/ciq217
|
Clin Infect Dis |
2011 |
| Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India.
doi:10.1128/JCM.00113-11
|
J Clin Microbiol |
2011 |
| Use of fluoroquinolone antibiotics leads to tuberculosis treatment delay in a South African gold mining community.
|
Int J Tuberc Lung Dis |
2011 |
| Isolation and characterization of "Pseudomonas andersonii" from four cases of pulmonary granulomas and emended species description.
doi:10.1128/JCM.02219-10
|
J Clin Microbiol |
2011 |
| Rapid detection of fluoroquinolone-resistant and heteroresistant Mycobacterium tuberculosis by use of sloppy molecular beacons and dual melting-temperature codes in a real-time PCR assay.
doi:10.1128/JCM.02271-10
|
J Clin Microbiol |
2011 |
| Evaluation of a line probe assay for the rapid detection of gyrA mutations associated with fluoroquinolone resistance in multidrug-resistant Mycobacterium tuberculosis.
doi:10.1099/jmm.0.024729-0
names it
|
J Med Microbiol |
2011 |
| Molecular characterization of fluoroquinolone resistance in Mycobacterium tuberculosis: functional analysis of gyrA mutation at position 74.
doi:10.1128/AAC.00920-10
names it
|
Antimicrob Agents Chemother |
2011 |
| Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico.
|
Jpn J Infect Dis |
2010 |
| [The effects of gene mutation related to drug resistance and drug efflux pump in extensively drug-resistant tuberculosis clinical isolates].
|
Zhonghua Jie He He Hu Xi Za Zhi |
2010 |
| [Novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries].
doi:10.5025/hansen.79.257
|
Nihon Hansenbyo Gakkai Zasshi |
2010 |
| Usefulness of resistant gene markers for predicting treatment outcome on second-line anti-tuberculosis drugs.
doi:10.1111/j.1365-2672.2010.04840.x
|
J Appl Microbiol |
2010 |
| Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model.
doi:10.1128/AAC.00968-10
|
Antimicrob Agents Chemother |
2010 |
| Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
doi:10.1128/AAC.00661-10
|
Antimicrob Agents Chemother |
2010 |
| [Molecular characterization of drug-resistant and extensive-drug resistant isolates of Mycobacterium tuberculosis in Shenzhen of China].
|
Zhonghua Jie He He Hu Xi Za Zhi |
2010 |
| Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.
doi:10.1093/jac/dkq202
|
J Antimicrob Chemother |
2010 |
| Branched intermediate formation stimulates peptide bond cleavage in protein splicing.
doi:10.1038/nchembio.371
|
Nat Chem Biol |
2010 |
| Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China.
doi:10.1016/j.jinf.2010.05.001
names it
|
J Infect |
2010 |
| Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.
doi:10.1128/JCM.01947-09
|
J Clin Microbiol |
2010 |
| Novel multiplex allele-specific PCR assays for the detection of resistance to second-line drugs in Mycobacterium tuberculosis.
doi:10.1093/jac/dkq047
|
J Antimicrob Chemother |
2010 |
| Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal.
doi:10.1093/jac/dkp452
|
J Antimicrob Chemother |
2010 |
| First report of molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates from a Tunisian hospital.
doi:10.1111/j.1469-0691.2009.03087.x
|
Clin Microbiol Infect |
2010 |
| Crystal structure of the DNA gyrase GyrA N-terminal domain from Mycobacterium tuberculosis.
doi:10.1002/prot.22600
names it
|
Proteins |
2010 |
| Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones.
doi:10.1128/JCM.01229-09
|
J Clin Microbiol |
2009 |
| Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam.
doi:10.1128/AAC.00541-09
|
Antimicrob Agents Chemother |
2009 |
| Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB.
doi:10.1128/AAC.00287-09
names it
|
Antimicrob Agents Chemother |
2009 |
| Epidemiologic characterization of culture positive Mycobacterium tuberculosis patients by katG-gyrA principal genetic grouping.
doi:10.2353/jmoldx.2009.080171
names it
|
J Mol Diagn |
2009 |
| Semisynthesis of membrane-attached prion proteins.
doi:10.1016/S0076-6879(09)62009-7
|
Methods Enzymol |
2009 |
| Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.
doi:10.1128/AAC.00050-09
|
Antimicrob Agents Chemother |
2009 |
| Prevalence of fluoroquinolone resistance among tuberculosis patients in Shanghai, China.
doi:10.1128/AAC.00177-09
|
Antimicrob Agents Chemother |
2009 |
| Genotypic rpoB and gyrA profiles for detection of rifampicin and fluoroquinolone susceptibilities of Mycobacterium tuberculosis isolates directly from clinical sputum specimens.
doi:10.1016/j.ijantimicag.2009.02.010
names it
|
Int J Antimicrob Agents |
2009 |
| Molecular detection of drug-resistant Mycobacterium tuberculosis with a scanning-frame oligonucleotide microarray.
doi:10.1007/978-1-59745-207-6_26
|
Methods Mol Biol |
2009 |
| The pentapeptide repeat proteins MfpAMt and QnrB4 exhibit opposite effects on DNA gyrase catalytic reactions and on the ternary gyrase-DNA-quinolone complex.
doi:10.1128/JB.01205-08
|
J Bacteriol |
2009 |
| Detection of mutations in Mycobacterium tuberculosis genome determining resistance to fluoroquinolones by hybridization on biological microchips.
doi:10.1007/s10517-008-0034-5
|
Bull Exp Biol Med |
2008 |
| A novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries.
doi:10.1099/jmm.0.2008/002600-0
|
J Med Microbiol |
2008 |
| [Drug resistance of multibacillary leprosy patients in Japan--results of molecular genetic analyses].
doi:10.5025/hansen.77.187
|
Nihon Hansenbyo Gakkai Zasshi |
2008 |
| Site-specific chemical modification of proteins with a prelabelled cysteine tag using the artificially split Mxe GyrA intein.
doi:10.1002/cbic.200800319
names it
|
Chembiochem |
2008 |
| [Rapid detection of mutations in the gyra gene of mycobacterium tuberculosis with relevance for the development of drug resistance against quinolones by real-time PCR on the LightCycler system].
doi:10.1055/s-2008-1038223
names it
|
Pneumologie |
2008 |
| Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia.
doi:10.1128/AAC.00036-08
|
Antimicrob Agents Chemother |
2008 |
| Fluoroquinolone resistance detection in Mycobacterium tuberculosis with locked nucleic acid probe real-time PCR.
|
Int J Tuberc Lung Dis |
2008 |
| Mutagenesis in the alpha3alpha4 GyrA helix and in the Toprim domain of GyrB refines the contribution of Mycobacterium tuberculosis DNA gyrase to intrinsic resistance to quinolones.
doi:10.1128/AAC.01380-07
names it
|
Antimicrob Agents Chemother |
2008 |
| Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates.
doi:10.1016/j.ijantimicag.2007.10.014
names it
|
Int J Antimicrob Agents |
2008 |
| Development of multiplex assay for rapid characterization of Mycobacterium tuberculosis.
doi:10.1128/JCM.01821-07
|
J Clin Microbiol |
2008 |
| Are all the DNA gyrase mutations found in Mycobacterium leprae clinical strains involved in resistance to fluoroquinolones?
doi:10.1128/AAC.01095-07
|
Antimicrob Agents Chemother |
2008 |
| The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
|
Lepr Rev |
2007 |
| [Investigation of Mycobacterium tuberculosis sensitivity to fluoroquinolone, by revealing gyrA gene mutations].
names it
|
Probl Tuberk Bolezn Legk |
2007 |
| Mycobacterium tuberculosis DNA gyrase as a target for drug discovery.
doi:10.2174/187152607781001763
|
Infect Disord Drug Targets |
2007 |
| Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid.
doi:10.1159/000109769
|
Chemotherapy |
2007 |
| Drug susceptibility of Spanish Mycobacterium tuberculosis complex isolates from animals.
doi:10.1016/j.tube.2007.08.004
|
Tuberculosis (Edinb) |
2007 |
| Polymorphisms in gyrA and gyrB genes among Mycobacterium avium subsp. paratuberculosis type I, II, and III isolates.
doi:10.1128/JCM.01411-07
names it
|
J Clin Microbiol |
2007 |
| Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.
doi:10.1093/jac/dkm061
|
J Antimicrob Chemother |
2007 |
| Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong.
doi:10.1093/jac/dkm054
|
J Antimicrob Chemother |
2007 |
| Validation of the agar proportion and 2 liquid systems for testing the susceptibility of Mycobacterium tuberculosis to moxifloxacin.
doi:10.1016/j.diagmicrobio.2006.08.018
|
Diagn Microbiol Infect Dis |
2007 |
| Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey.
doi:10.1093/jac/dkm038
|
J Antimicrob Chemother |
2007 |
| Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones.
doi:10.1128/AAC.01282-06
|
Antimicrob Agents Chemother |
2007 |
| Association between Mycobacterium tuberculosis Beijing/W lineage strain infection and extrathoracic tuberculosis: Insights from epidemiologic and clinical characterization of the three principal genetic groups of M. tuberculosis clinical isolates.
doi:10.1128/JCM.01459-06
|
J Clin Microbiol |
2007 |
| Detection of multidrug resistance in Mycobacterium tuberculosis.
doi:10.1128/JCM.00750-06
|
J Clin Microbiol |
2007 |
| A drug-resistant leprosy case detected by DNA sequence analysis from a relapsed Mexican leprosy patient.
|
Rev Latinoam Microbiol |
2006 |
| The key DNA-binding residues in the C-terminal domain of Mycobacterium tuberculosis DNA gyrase A subunit (GyrA).
doi:10.1093/nar/gkl695
names it
|
Nucleic Acids Res |
2006 |
| Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing.
doi:10.1128/JCM.01916-06
names it
|
J Clin Microbiol |
2006 |
| Glutamate racemase from Mycobacterium tuberculosis inhibits DNA gyrase by affecting its DNA-binding.
doi:10.1093/nar/gkl704
|
Nucleic Acids Res |
2006 |
| Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones.
doi:10.1128/AAC.00944-06
|
Antimicrob Agents Chemother |
2006 |
| Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
doi:10.1093/jac/dkl388
|
J Antimicrob Chemother |
2006 |
| [Study on mutations of gyrA gene of tuberculosis quinolone-tolerant isolates in coal workers' pneumoconiosis].
names it
|
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi |
2006 |
| Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes.
doi:10.1128/AAC.50.1.104-112.2006
|
Antimicrob Agents Chemother |
2006 |
| Temperature-mediated heteroduplex analysis for the detection of drug-resistant gene mutations in clinical isolates of Mycobacterium tuberculosis by denaturing HPLC, SURVEYOR nuclease.
doi:10.1016/j.micinf.2005.06.008
|
Microbes Infect |
2006 |
| Mutations in the gyrA and gyrB genes of fluoroquinolone-resistant Mycobacterium tuberculosis from TB patients in Thailand.
names it
|
Southeast Asian J Trop Med Public Health |
2005 |
| [Polymerase chain reaction-single strand conformation polymorphism analysis combined with nucleic acid hybridization to detect ofloxacin-resistant Mycobacterium tuberculosis mutation selected in vitro].
|
Zhonghua Jie He He Hu Xi Za Zhi |
2005 |
| Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003.
doi:10.1093/jac/dki353
|
J Antimicrob Chemother |
2005 |
| Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis.
doi:10.1128/AAC.49.7.2928-2933.2005
names it
|
Antimicrob Agents Chemother |
2005 |
| A monoclonal antibody that inhibits mycobacterial DNA gyrase by a novel mechanism.
doi:10.1093/nar/gki622
|
Nucleic Acids Res |
2005 |
| Validation of the use of Middlebrook 7H10 agar, BACTEC MGIT 960, and BACTEC 460 12B media for testing the susceptibility of Mycobacterium tuberculosis to levofloxacin.
doi:10.1128/JCM.42.11.5225-5228.2004
|
J Clin Microbiol |
2004 |
| Molecular strain identification of the Mycobacterium tuberculosis complex in archival tissue samples.
doi:10.1136/jcp.2003.015719
|
J Clin Pathol |
2004 |
| [Multi-drug resistant Mycobacterium leprae from patients with leprosy].
doi:10.5025/hansen.73.227
|
Nihon Hansenbyo Gakkai Zasshi |
2004 |
| Detection of Mycobacterium tuberculosis genotypic groups by a duplex real-time PCR targeting the katG and gyrA genes.
doi:10.1016/j.mimet.2004.06.012
names it
|
J Microbiol Methods |
2004 |
| [Molecular identification of mycobacteria and detection of antibiotic resistance].
|
Ann Biol Clin (Paris) |
2004 |
| Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis.
doi:10.1086/421501
|
J Infect Dis |
2004 |
| [Study on the gene mutation of quinolone-resistant Mycobacterium tuberculosis isolated from Sichuan Province].
|
Sichuan Da Xue Xue Bao Yi Xue Ban |
2004 |
| Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity.
doi:10.1128/AAC.48.4.1281-1288.2004
|
Antimicrob Agents Chemother |
2004 |
| Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.
doi:10.1128/AAC.48.2.596-601.2004
names it
|
Antimicrob Agents Chemother |
2004 |
| Mycobacterium tuberculosis isolates belonging to katG gyrA group 2 are associated with clustered cases of tuberculosis in Italian patients.
doi:10.1099/jmm.0.05471-0
names it
|
J Med Microbiol |
2004 |
| Elevation of Mycobacterium tuberculosis subsp. caprae Aranaz et al. 1999 to species rank as Mycobacterium caprae comb. nov., sp. nov.
doi:10.1099/ijs.0.02532-0
|
Int J Syst Evol Microbiol |
2003 |
| Drug susceptibility testing of Mycobacterium tuberculosis to fluoroquinolones: first experience with a quality control panel in the Nordic-Baltic collaboration.
|
Int J Tuberc Lung Dis |
2003 |
| Characterization of the Manila family of Mycobacterium tuberculosis.
doi:10.1128/JCM.41.6.2723-2726.2003
|
J Clin Microbiol |
2003 |
| Detection of gene mutations related with drug resistance in Mycobacterium leprae from leprosy patients using Touch-Down (TD) PCR.
doi:10.1016/S0928-8244(03)00038-5
|
FEMS Immunol Med Microbiol |
2003 |
| Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis.
doi:10.1128/AAC.47.4.1241-1250.2003
|
Antimicrob Agents Chemother |
2003 |
| Identification of mycobacterial species by PCR sequencing of quinolone resistance-determining regions of DNA gyrase genes.
doi:10.1128/JCM.41.3.1311-1315.2003
|
J Clin Microbiol |
2003 |
| Molecular analysis of Mycobacterium tuberculosis DNA from a family of 18th century Hungarians.
doi:10.1099/mic.0.25961-0
|
Microbiology (Reading) |
2003 |
| An orphan gyrB in the Mycobacterium smegmatis genome uncovered by comparative genomics.
doi:10.1007/BF02715907
|
J Genet |
2002 |
| [The importance of allergic skin test with Johnin, antibody ELISA, cultural fecal test as well as vaccination for the sanitation of three chronically paratuberculosis-infected dairy herds in Rhineland-Palatinate].
|
Dtsch Tierarztl Wochenschr |
2002 |
| Development of a positive genetic selection system for inhibition of protein splicing using mycobacterial inteins in Escherichia coli DNA gyrase subunit A.
|
J Mol Microbiol Biotechnol |
2002 |
| Creation of an artificial bifunctional intein by grafting a homing endonuclease into a mini-intein.
doi:10.1016/s0022-2836(02)00912-9
|
J Mol Biol |
2002 |
| DNA gyrase genes in Mycobacterium tuberculosis: a single operon driven by multiple promoters.
doi:10.1128/JB.184.19.5449-5456.2002
|
J Bacteriol |
2002 |
| Establishment of intein-mediated protein ligation under denaturing conditions: C-terminal labeling of a single-chain antibody for biochip screening.
doi:10.1021/bc025534z
|
Bioconjug Chem |
2002 |
| Characterization of pyrazinamide and ofloxacin resistance among drug resistant Mycobacterium tuberculosis isolates from Singapore.
doi:10.1016/s1201-9712(02)90136-0
|
Int J Infect Dis |
2002 |
| Functional characterisation of mycobacterial DNA gyrase: an efficient decatenase.
doi:10.1093/nar/30.10.2144
|
Nucleic Acids Res |
2002 |
| Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India.
doi:10.1128/AAC.46.2.443-450.2002
|
Antimicrob Agents Chemother |
2002 |
| Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy.
doi:10.1086/324623
|
Clin Infect Dis |
2002 |
| Typing of drug resistant isolates of Mycobacterium tuberculosis from India using the IS6110 element reveals substantive polymorphism.
doi:10.1016/s1567-1348(01)00014-4
|
Infect Genet Evol |
2001 |
| Multidrug resistant Mycobacterium leprae from patients with leprosy.
doi:10.1128/AAC.45.12.3635-3639.2001
|
Antimicrob Agents Chemother |
2001 |
| Distribution of GyrA intein in non-tuberculous mycobacteria and genomic heterogeneity of Mycobacterium gastri.
doi:10.1016/s0014-5793(01)03037-x
names it
|
FEBS Lett |
2001 |
| Mycobacterium tuberculosis phylogeny reconstruction based on combined numerical analysis with IS1081, IS6110, VNTR, and DR-based spoligotyping suggests the existence of two new phylogeographical clades.
doi:10.1007/s002390010255
|
J Mol Evol |
2001 |
| Cleavage and purification of intein fusion proteins using the Streptococcus gordonii spex system.
doi:10.1081/PB-100104909
|
Prep Biochem Biotechnol |
2001 |
| Immune reactions in cattle after immunization with a Mycobacterium paratuberculosis vaccine and implications for the diagnosis of M. paratuberculosis and M. bovis infections.
doi:10.1046/j.1439-0450.2001.00443.x
|
J Vet Med B Infect Dis Vet Public Health |
2001 |
| Monoclonal antibodies to mycobacterial DNA gyrase A inhibit DNA supercoiling activity.
doi:10.1046/j.1432-1327.2001.02077.x
|
Eur J Biochem |
2001 |
| Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis.
doi:10.1093/jac/47.4.447
|
J Antimicrob Chemother |
2001 |
| Transmission dynamics and molecular characterization of Mycobacterium tuberculosis isolates with low copy numbers of IS6110.
doi:10.1128/JCM.39.1.217-221.2001
|
J Clin Microbiol |
2001 |
| Genetic diversity and evidence for acquired antimicrobial resistance in Mycobacterium tuberculosis at a large hospital in South India.
doi:10.1016/s1201-9712(00)90075-4
|
Int J Infect Dis |
2000 |
| Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations.
doi:10.1086/315708
|
J Infect Dis |
2000 |
| Characterization of Mycobacterium tuberculosis isolates from patients in Houston, Texas, by spoligotyping.
doi:10.1128/JCM.38.2.669-676.2000
|
J Clin Microbiol |
2000 |
| Molecular characterization of mycobacteria isolated from seals.
doi:10.1099/00221287-145-9-2519
|
Microbiology (Reading) |
1999 |
| Mycobacterium tuberculosis subsp. caprae subsp. nov.: a taxonomic study of a new member of the Mycobacterium tuberculosis complex isolated from goats in Spain.
doi:10.1099/00207713-49-3-1263
|
Int J Syst Bacteriol |
1999 |
| The cyclization and polymerization of bacterially expressed proteins using modified self-splicing inteins.
doi:10.1074/jbc.274.26.18359
|
J Biol Chem |
1999 |
| Molecular epidemiologic evaluation of transmissibility and virulence of Mycobacterium tuberculosis.
doi:10.1128/JCM.37.6.1764-1770.1999
|
J Clin Microbiol |
1999 |
| In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone.
doi:10.1128/AAC.43.5.1077
|
Antimicrob Agents Chemother |
1999 |
| Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C-8 methoxyl group on survival in liquid media and in human macrophages.
doi:10.1128/AAC.43.3.661
|
Antimicrob Agents Chemother |
1999 |
| Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru.
doi:10.1054/tuld.1998.0013
|
Tuber Lung Dis |
1998 |
| [Mechanisms of drug-resistance in mycobacteria].
|
Nihon Rinsho |
1998 |
| [Multidrug-resistant tuberculosis. 2. Mechanisms of drug-resistance in Mycobacterium tuberculosis--genetic mechanisms of drug-resistance].
|
Kekkaku |
1998 |
| Fluoroquinolone action against mycobacteria: effects of C-8 substituents on growth, survival, and resistance.
doi:10.1128/AAC.42.11.2978
|
Antimicrob Agents Chemother |
1998 |
| Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria.
doi:10.1128/AAC.42.8.2084
|
Antimicrob Agents Chemother |
1998 |
| Inteins in mycobacterial GyrA are a taxonomic character.
doi:10.1099/00221287-144-2-589
names it
|
Microbiology (Reading) |
1998 |
| Crystal structure of GyrA intein from Mycobacterium xenopi reveals structural basis of protein splicing.
doi:10.1038/nsb0198-31
names it
|
Nat Struct Biol |
1998 |
| Molecular techniques in the diagnosis of drug-resistant tuberculosis.
|
Ann Acad Med Singap |
1997 |
| [Rapid diagnosis of tuberculosis].
|
Kekkaku |
1997 |
| Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinical Trials Group 222 Protocol Team.
doi:10.1097/00002030-199712000-00011
|
AIDS |
1997 |
| The Mycobacterium xenopi GyrA protein splicing element: characterization of a minimal intein.
doi:10.1128/jb.179.20.6378-6382.1997
names it
|
J Bacteriol |
1997 |
| Nonradioactive single-strand conformation polymorphism analysis for detection of fluoroquinolone resistance in mycobacteria.
doi:10.1007/BF01726372
|
Eur J Clin Microbiol Infect Dis |
1997 |
| Gene arrangement and organization in a approximately 76 kb fragment encompassing the oriC region of the chromosome of Mycobacterium leprae.
doi:10.1099/13500872-142-11-3147
|
Microbiology (Reading) |
1996 |
| Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis.
doi:10.1093/infdis/174.5.1127
|
J Infect Dis |
1996 |
| Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis.
doi:10.1128/AAC.40.9.2054
|
Antimicrob Agents Chemother |
1996 |
| Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.
doi:10.1128/AAC.40.8.1768
|
Antimicrob Agents Chemother |
1996 |
| gyrA of ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Hong Kong.
doi:10.1093/jac/37.5.1032
names it
|
J Antimicrob Chemother |
1996 |
| Homing events in the gyrA gene of some mycobacteria.
doi:10.1073/pnas.93.8.3410
names it
|
Proc Natl Acad Sci U S A |
1996 |
| Organization of the origins of replication of the chromosomes of Mycobacterium smegmatis, Mycobacterium leprae and Mycobacterium tuberculosis and isolation of a functional origin from M. smegmatis.
doi:10.1111/j.1365-2958.1996.tb02617.x
|
Mol Microbiol |
1996 |
| Mycobacterium smegmatis DNA gyrase: cloning and overexpression in Escherichia coli.
doi:10.1099/13500872-141-12-3029
|
Microbiology (Reading) |
1995 |
| Mechanisms of resistance to fluoroquinolones: state-of-the-art 1992-1994.
doi:10.2165/00003495-199500492-00006
|
Drugs |
1995 |
| Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.
names it
|
J Infect Dis |
1994 |
| Characterization of mutations in Mycobacterium smegmatis involved in resistance to fluoroquinolones.
doi:10.1128/AAC.38.9.1991
|
Antimicrob Agents Chemother |
1994 |
| Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.
doi:10.1093/infdis/170.2.479
names it
|
J Infect Dis |
1994 |
| Molecular cloning of gyrA and gyrB genes of Mycobacterium tuberculosis: analysis of nucleotide sequence.
names it
|
Biochem Mol Biol Int |
1994 |
| Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations.
doi:10.1128/AAC.38.4.773
names it
|
Antimicrob Agents Chemother |
1994 |
| Amplification and nucleotide sequence of the quinolone resistance-determining region in the gyrA gene of mycobacteria.
doi:10.1111/j.1574-6968.1994.tb06674.x
names it
|
FEMS Microbiol Lett |
1994 |
| A PCR method for the sequence analysis of the gyrA, polA and rnhA gene segments from mycobacteria.
doi:10.1016/0378-1119(93)90481-h
names it
|
Gene |
1993 |
| Characterization of Escherichia coli men mutants defective in conversion of o-succinylbenzoate to 1,4-dihydroxy-2-naphthoate.
doi:10.1128/jb.152.3.1132-1137.1982
|
J Bacteriol |
1982 |